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Abstract 
The presence of emerging contaminants in water has become a serious concern in recent times. 
There are no standard treatment processes designed to remove pharmaceuticals, such as ibuprofen 
(IBP), from drinking water. The objective of this project was to study the adsorption of IBP from water 
onto different adsorbents. The adsorbents evaluated included Filtrasorb 200 GAC, PWA PAC, Purolite 
A530E, Amberlite XAD-4, Amberlite XAD-7, and Optipore L-493. The concentration of IBP after 
treatment was quantified using a UV-vis spectrophotometer. All adsorbents with the exception of 
Amberlite XAD-7 achieved at least 96% removal. Amberlite XAD-7 did not provide adequate removal. 
However, PWA PAC and Purolite A530E were significantly more efficient in removing IBP from water. 
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Executive Summary 
The presence of emerging contaminants in water has become a serious concern. Typical water 
treatment facilities are not designed to remove pharmaceuticals from drinking water. These drugs, both 
prescription and over-the-counter, can end up in water supplies. There are many concerns that this is a 
result of flushing drugs, but many drugs are not completely metabolized by the body, and enter the 
environment after passing through wastewater treatment facilities (FDA, 2011). The effluents from such 
treatment facilities are discharged into bodies of water that can end up in water supplies, from which 
drinking water is taken. 
Removing ibuprofen from water is an important issue to address through research and the 
development of effective technologies for removal.  Ibuprofen is a nonsteroidal anti-inflammatory drug 
(NSAID). NSAIDs include 19 anti-inflammatory drugs, many of which are over the counter. The drug’s 
wide usage is why it is being found in waterways. Despite current research in ibuprofen removal, little 
has been done to look at the effectiveness of adsorption methods.  
The purpose of this project was to investigate the treatability of ibuprofen in drinking water using 
adsorption methods.  Six different adsorbents were researched including PWA powdered activated 
carbon (PAC), Filtrasorb 200 granular activated carbon (GAC), Amberlite XAD-4, Amberlite XAD-7, 
Purolite A530E, and Optipore L-493. These adsorbents were tested using batch adsorption in both 
equilibrium experiments and time trials. For the equilibrium trials, samples with different masses of 
each adsorbent were tested at three pHs (4, 5, and 7) for 24 hour contact periods in 42mL vials using an 
end-over-end mixer. After 24 hours, the adsorbance of the sample was measured with a UV-vis 
spectrophotometer to determine the concentration of IBP. This data was used to find the smallest 
amount of adsorbent needed to achieve more than 96% removal. Time trials were conducted for each 
adsorbent to determine the optimal contact time and the time required for each adsorbent to achieve 
equilibrium. Since the equilibrium results for pH 5 did not prove significant differences from the results 
for pH 4, and because the pKa is within this range, kinetics testing at pH 5 was no conducted.  
Overall, four adsorbents were successful in the removal of ibuprofen for both pHs. These 
adsorbents were PWA PAC, Filtrasorb 200 GAC, Purolite A530E, and Optipore L-493. For both pH 4 and 
7, these four adsorbents reached 96% removal within the equilibrium period. In terms of all of the 
adsorbents, pH 4 had more general success with five out of six adsorbents reaching high percentages of 
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removal. However, pH 7 had higher percentage removal in a shorter contact time but with fewer 
adsorbents reaching those levels.  
Out of all of the experiments PWA powdered activated carbon at pH 7 proved to be the most 
effective in the removal of ibuprofen from water. PWA powdered activated carbon achieved 98.6% 
removal within one hour of contact time for pH 4 and 99.7% removal within one hour of contact time 
for pH 7 making it the most successful adsorbent tested in these trials. For this project, all aqueous 
solutions were filtered using a 0.22µm syringe filter. This was successful in removing the PWA from the 
solution, however would not be feasible for large volumes or constant flow.  
While PWA powdered activated carbon was successful in treating IBP-contaminated water, it is 
recommended that Purolite A530E be considered. Purolite A530E was comparable to PWA in the 
removal of ibuprofen from water at pH 7. Though this adsorbent did not reach equilibrium as quickly as 
PWA, its physical properties allow it to readily settle out of aqueous solutions without the need for 
filtration. Since streams and groundwater typically range from pH 6.5 and 8.5 and natural water ranges 
from pH 5 to 8.5, Purolite A530E would be an effective adsorbent for removing IBP from water. 
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MQP Capstone Design Requirement 
In partial fulfillment of this Major Qualifying Project (MQP), the design of an  activated carbon 
contactor for a hypothetical treatment plant was completed. The design demonstrates an understanding 
of the adsorption process researched by this MQP, and also shows knowledge of water treatment 
design. The design specifications for the activated carbon contactor were based on given information on 
the emerging presence of ibuprofen in drinking water and the experimental data gathered by this MQP. 
The contactor was designed for a drinking water facility that whose customers have growing concerns 
for the increase in ibuprofen found in their water. The system is to be implemented after the filtration 
step and before chlorination and storage/discharge. 
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Chapter 1: Introduction 
Currently, the global pharmaceutical market is valued at US$300 billion a year, and expected to 
grow in the next three years (WHO, 2013). This market is expected to grow in the future as better health 
care is brought to countries and areas of the world that previously did not have such. In addition to the 
growth of prescription pharmaceuticals the use of over-the-counter (OTC) drugs is increasing. In a study 
done by the FDA, 69% of Americans answering the survey reported to purchasing an OTC pain reliever in 
the past six months (FDA, 2009). These drugs, both prescription and over-the-counter, can end up in 
water supplies. There are many concerns that this is a result of flushing drugs, but many drugs are not 
completely metabolized by the body, and enter the environment after passing through wastewater 
treatment facilities (FDA, 2011). The effluents from such treatment facilities feed into bodies of water 
that can end up in water supplies, which drinking water is taken from. In a study done by the US 
Geological Survey, one of more of 95 chemicals tested for, which included but were not limited to 
pharmaceuticals and insect repellants, were found in 80% of streams samples (2002).   
The presence of emerging contaminants in water has become a serious concern in recent times.  
Water pollution has been a significant problem for the past 40 years in the United States.  There have 
been efforts to address water pollution since the Federal Water Pollution Control Amendments of 1972 
and evolved with the Clean Water Act of 1977 and the Water Quality Act of 1987. The emerging 
problem is that the contaminants being found in water today do not respond to the treatments that are 
a part of standard water treatment facilities and are also newer chemicals that are not routinely tested 
for. For example, of the 95 chemicals tested for in the US Geological Survey study, only 14 have drinking 
water standards established for them (2002). One contaminant in particular that is being found in water 
is the pharmaceutical ibuprofen.  It is a widely administered drug used for the relief of symptoms of 
arthritis, fever, and to reduce pain.  In the past two decades there has been more quantitative data 
regarding the occurrence and concentrations of ibuprofen in water. 
There have been some implications of long-term effects on the ecosystem from ibuprofen by its 
killing of the species Lemna minor (Zuccato et al., 2005).  In a recent study done by the World Health 
Organization, the measured concentrations of selected pharmaceuticals in aquatic environments of the 
United Kingdom were observed and ibuprofen was the leading contaminant found with the highest 
levels detected in comparison to other pharmaceuticals including Erythromycin, Bleomycin, and others 
(2011).  This trend will only grow, as the market for OTC pharmaceuticals is expected to grow steadily 
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from 2012 to 2022. This high demand is due to demographic trends and awareness about self-
medication. Self-medication is becoming increasingly popular and as a result many companies are 
making moves to change some prescription-only drugs to OTC-available. With the worldwide market for 
OTC pharmaceuticals estimated to reach $80.7 billion in 2014, the expectation is that the use of NSAIDs 
will continue to increase, therefore making it necessary to look into treatment technologies that are 
able to remove such chemicals (Visiongain, 2012).   
Removing ibuprofen from water is an important issue to address through research and the 
development of effective technologies for removal.  Ibuprofen is an NSAID pharmaceutical nonsteroidal 
anti-inflammatory drug. NSAIDs include 19 anti-inflammatory drugs, many of which are over the 
counter. The drug’s wide usage is why it is being found in waterways. Despite current research in 
ibuprofen removal, little has been done to look at the effectiveness of adsorption methods.  There have 
been successes in removal with biological processes but there is a need for research in different types of 
adsorption.  Biological treatments are secondary treatments common in wastewater treatment facilities, 
but not in drinking water facilities.  Adsorption methods may be effective for removing ibuprofen. 
Adsorption has become a popular and often used technique for the removal of pollutants. 
Adsorption can be used on the large scale as well as on a small scale such as in household water 
filtration systems.  Of the more common adsorbents, activated carbon continues to be the most widely 
used adsorbent for the purification of water with low pollutant concentration (Mestre et al., 2008). The 
purpose of this project was to investigate different adsorbents for removing ibuprofen from water, such 
as activated carbons and ion exchange resins.  Based on the research, recommendations were made 
about the usefulness of specific adsorption processes for treating ibuprofen. 
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Chapter 2: Background 
2.1 Compounds of Emerging Concern 
Water pollution has been a major concern in America for a long time.  In 1948 the issue was first 
addressed with the Federal Water Pollution Control Act.  As years went on and the public concern and 
awareness about controlling water pollution increased, the Clean Water Act (CWA) was amended.  The 
purpose of this 1972 law is to restore and maintain “the chemical, physical, and biological integrity of 
the Nation’s waters” (33 U.S.C. §1251 et seq.,1972).  There are many different sources of pollutants 
including: municipal sewage, industrial waste, agricultural runoff, petrochemicals, and stormwater 
runoff.  
The conventional treatment processes for drinking water facilities include: rapid mix, 
coagulation / flocculation, sedimentation, filtration, and disinfection.  These processes are good for 
removing typical non-anthropogenic pollutants, but the problem now is the presence of different 
compounds of emerging concern.  An example of this is pharmaceuticals, which have been classified in 
the Pharmaceuticals and Personal Care Products (PPCPs) category.  Especially in developed countries like 
the United States, there are thousands of pharmaceutical chemicals being used today (Rounds et al., 
2009).  An estimated 25% to 33% of pharmaceuticals sold are incorrectly disposed of in landfills and 
wastewater treatment plants (Lubliner, 2008), and these pharmaceuticals can end up in the drinking 
water supply, as seen in Figure 1.  Although the fact that there are trace amounts of pharmaceuticals in 
water, the risks are still not completely known (Kümmerer, 2010). 
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Figure 1: Pharmaceuticals Entering Water (Kümmerer, 2010) 
2.1.1 Ibuprofen 
 An example of such a pharmaceutical that has been found in various waters is ibuprofen.  This 
common nonsteroidal anti-inflammatory drug (NSAID) is used primarily to treat minor pain, fever, and 
inflammation (Britannica, 2012).  Ibuprofen works by inhibiting prostaglandin synthesis, which causes 
inflammation, by interfering with the enzyme cyclooxgenase needed to catalyze the conversion of 
arachidonic acid into prostaglandins (Chemistry, 2012).  The pKa of ibuprofen has been documented at 
4.593±0.051 (Vincenteño et al., 2010). The chemical dissociates as it becomes more basic and exceeds 
the pKa. Figure 2 shows the chemical structure of ibuprofen. 
 
Figure 2: Chemical Structure of Ibuprofen (Hawthorne Pharmaceuticals, 2005) 
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 Although the risks for pharmaceuticals like ibuprofen being in the environment are not 
completely known, there are still potential risks.  The next section discusses the presence of ibuprofen in 
the environment and also the related potential risks.   
2.2 Ibuprofen in the Environment 
 As people are becoming aware of what is being put into our bodies, so are people taking notice 
to what is leaving our bodies and entering our ecosystems. Over the past several decades, the 
implementation of environmental laws, which control the amounts of chemicals released into the 
environment by industries, companies and households, have been continually reformed in an attempt to 
keep any dangerous chemicals out of water supplies, where they can easily reach animals and humans. 
All over the world initiatives have taken place to keep raw, reclaimed, and drinking water sources free 
from contaminants.  
2.2.1 Occurrence 
 Throughout the past couple of decades significantly more quantitative research has been 
conducted on many types of drugs released into the environment including ibuprofen. One study 
showed that 77%-85% of ingested Ibuprofen is excreted in urine (Rainsford, 1999). In 2002, a study was 
performed on 139 streams across the United States to test for hundreds of different pharmaceuticals 
(Kolpin et al. 2002). It was found that 9.5% of the streams tested had traces of ibuprofen in them, with a 
minimum concentration of roughly 0.018 µg/L and a maximum of roughly 1.0 µg/L.  Around the same 
time in Germany, a study was done on sewage effluents looking for many of the same drugs and 
ibuprofen was found at an average concentration of 0.22 µg/l (Heberer et al. 2002). In the U.S., another 
study was done and found 0.90 – 2.11 µg/L of ibuprofen in raw and reclaimed water sources and nearly 
1.35 µg/L in drinking water (Richardson, 2007). Only five years after this study, the same streams across 
America were tested and the concentration was found to be close to 1.0µg/L more than in 2002.  
2.2.2 Risk and Resistance of Ibuprofen 
 As concentrations of ibuprofen are being found in the environment, the thought of how the 
chemicals might affect organisms in aquatic ecosystems is becoming a concern. Although the relative 
amounts of ibuprofen found are quite small, it is important to understand that the chemical undergoes 
changes as it metabolizes in an organism’s digestive system. The conjugate groups, however changed, 
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retain the same low level of toxicity as the parent compound. Ibuprofen metabolites include hydroxy 
and carboxyibuprofen (Nikolaou et al., 2007).  
Several studies have been conducted on aquatic life looking for how concentrations of ibuprofen 
might affect these species. A cyanobacterium, Synechocystis sp. PCC6803, was specifically looked at 
along with a species of water plant called duckweed, Lemna minor (Zuccato et al., 2005). Looking for 
unnatural growth in the two organisms, they tested the ability to grow at different concentrations. The 
Synechocystis exhibited a strong and rapid growth at all concentrations of ibuprofen. Lemna on the 
other hand showed a declined ability to grow in an exponential decreasing manner. The effects on 
Lemna have been the most severe recorded to date.   
 The impact on the ecosystem of losing one species like Lemna minor to the harmful effects of a 
contaminating drug could be detrimental. In a small ecosystem the loss of one organism could mean 
disaster for most all other organisms in the ecosystem. In the case of humans there is a growing concern 
with prolonged use of ibuprofen (Roizman, 2011). Many health specialists are concerned that ibuprofen 
can cause gastrointestinal, cardiovascular, kidney, and brain conditions.  
2.3 Ibuprofen Removal in Wastewater  
 Over the past decade the removal of ibuprofen from wastewater has been studied.  Biological 
removal processes have proven to be the most effective, unfortunately they are very expensive and the 
technology would be hard to implement in most treatment facilities (Yamamoto et al., 2008). The 
biological processes that were effective included the activated sludge biodegradation (Maeng et al., 
2011) and membrane bioreactor (Matamoros et al., 2008). With the limitation posed by biological 
removal processes, it is not used for drinking water applications. Ultraviolet (UV) radiation, ozone 
oxidation and hollow fiber membranes (polypropylene fibers) were proven to be successful in the 
removal of ibuprofen from wastewater (Williams et al., 2011). 
 Liquid phase adsorption is also a feasible treatment method and is one of the most extensively 
used methods for the removal of organic pollutants from industrial wastewater (Rogue-Malherbe, 
2007). Some examples of this commonly used adsorbents process is activated carbon, silica, zeolites, 
and resins.  Adsorption is a method used both in wastewater treatment and water treatment.  
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2.4 Methods for Ibuprofen Removal in Water Treatment 
A major issue with today’s drinking water supply is the influx of pharmaceuticals such as 
ibuprofen and other NSAIDs being introduced into the water in large quantities. Whether being flushed 
down the drain by manufactures or by households, the increasing presence of these contaminants is 
cause for new research and technologies to be developed for their removal. Much like wastewater, 
there are methods such as UV and ozone oxidation, activated sludge biodegradation (Maeng et al., 
2011), and adsorption (Rogue-Malherbe, 2007); all of which are effective and can be found in water 
treatment plants across the globe. 
However effective many current methods are on large-scale applications; adsorption processes 
show promise on a smaller scale. With adsorbents already in use on a household level, i.e. GAC water 
filters, and with many different types of adsorbents available; this research investigated the possible 
uses of these adsorbents and explored the new synthetic adsorbents available as well as the older ones 
currently being used.   
2.5 Adsorption  
Adsorption has become a popular and often used technique for the removal of pollutants. Of the 
more common adsorbents, activated carbon continues to be the most widely used for the purification of 
water with low pollutant concentration (Mestre et al., 2008). Adsorption commonly refers to when 
atoms move from a bulk phase onto the surface of either a solid or a liquid. An example of this is when 
impurities are filtered from liquids or gases. This project focused on liquid phase adsorption. 
Adsorption in the liquid phase is affected by many factors. Simple factors such as pH, type of adsorbent, 
solubility of adsorbent in the solvent, and temperature all have an influence on liquid phase adsorption 
(Rogue-Malherbe, 2007). For this reason, there is much more research done on gas phase adsorption 
than liquid phase adsorption.  
Adsorption is a process with three steps. The first of these steps is for the contaminant to be 
transferred from the bulk phase to the outer surface of the adsorbent material. In the second step, the 
contaminant molecule diffuses from the smaller of the areas of the outer surface into the areas within 
each adsorbent. This includes the macropores, transitional pores, and micropores (EPA, 2000). The third 
and last step is when the contaminant molecule is adsorbed into the surface of the pore structure within 
the adsorbent. Figure 3 below shows these three steps of adsorption. 
 18 
 
 
Figure 3: Three Steps of Adsorption (EPA, 2000) 
Adsorption may take place at different magnitudes of bonding. The strength of such interactions 
can be divided into two classifications: weak interactions and strong interactions. A weak interaction, or 
<40 kJ/mol, is the same as the interactions between molecules in liquids and allow for what is known as 
physical adsorption or physisoption (Sivasankar, 2008).  Strong interactions, or >40 kJ/mol, are much like 
the interactions between atoms within a molecule (e.g. covalent bonds) and allow for chemical 
adsorption, or chemisorption (Sivasankar, 2008). The biggest difference between the two is that while in 
physisorption the adsorbed molecule remains intact, where in chemisorption the molecule may be 
broken into pieces upon the surface. When the molecule is fragmented on the surface of the adsorbent, 
the process is called dissociative chemisorption.  
Pore structure is very important when looking at adsorbents. Usually micropores are considered 
active sites where the adsorption potential is higher (Ania and Bandosz, 2005). In a recent study, it was 
found that the carbon with the lowest narrow micropore volume outperformed ibuprofen retention on 
the remaining adsorbents. This finding suggests that the size of ibuprofen and perhaps its shape impact 
its ability to get into small pores of some activated carbons. This stands true even though two molecular 
dimensions of ibuprofen are smaller than the sizes of the ultramicropores width less than 0.7 nm. This 
could mean that size exclusion effects are occurring. Therefore to understand the adsorption process 
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the volume, dimensions, and shape of the narrow micropores should be taken into account (Mestre, 
2008). 
 
Figure 4:  Pore Structure of an Adsorbent (EPA, 2000) 
There are many materials available that can act as adsorbents. The most common types of 
adsorbents being used specifically for the purpose of controlling pollution are activated carbons, zeolites 
(also known as molecular sieves), and synthetic polymers (EPA, 2000). These different types of 
adsorbents could have varying effects on the treatment of different contaminants.  
 An example of a specific type of adsorption method, and the one that this paper focused on, is 
batch adsorption. Batch adsorption consists of contacting an adsorbent with the wastewater for a given 
period of time in a mixing vessel (Armenante).  Today there are many different adsorbents that have 
been successful in treating different contaminants and pharmaceuticals in water 
Activated Carbons 
Activated carbon is one of the more popular adsorbents and is currently a low-cost accessible 
method for different types of pollution control. It can be created from various raw materials such as 
coal, coconut, nutshells, wood, and petroleum-based products (EPA, 2000). To turn one of these raw 
materials into an activated carbon, there is a simple activation process. This process takes place in two 
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steps. The first step is to pyrolyze the feedstock. This means to heat the material without the presence 
of air to a high temperature (e.g., 1,100°F or 590°C) to rid of any volatile material. This process results in 
carbon as well as small amounts of ash. The objective of the second step is to increase the surface area. 
To do this, the carbon is “activated” by using air, steam or carbon dioxide at high temperatures. This 
increases the pore structure because these gases tend to “attack” the carbon. Several factors of this 
process affect the adsorption qualities of the carbon, such as the temperatures that are involved in the 
process, the amount of oxygen that is present, and the type of feedstock (EPA, 2000). In a recent study, 
the potential of low-cost high-value activated carbons obtained from wastes were tested. Cork powder 
and plastic residues were transformed into activated carbons to test the removal of ibuprofen. The 
waste-derived carbons proved a better adsorption capacity than many commercial adsorbents (Mestre 
et al., 2008). 
Activated carbon is used to control emissions of a wide variety of organic solvents as well as 
some toxic gases as a result of its nonpolar surface. For example, the adsorbent is used for odor control 
in many industrial facilities. It is also popularly used to adsorb odorous or colored substances from 
liquids in addition to gases. For treatment of gases in gas phase adsorption systems, carbons are 
manufactured in a granular form or in a carbon fiber form. The bulk density of the granular-pellet-
packed activated carbon beds can range from 5 to 30 lbm/ft3, which is equal to 0.08 to 0.48 g/cm3, 
depending on the internal pore structure of the carbon. The pore structure of activated carbon also has 
a significantly high range. For example, total surface area of the macropores and micropores within 
activated carbon can range from 600 to 1,600 m2/g (EPA, 2000). 
Adsorption is a very popular method for treating chemical contaminants, and activated carbon 
continues to remain one of the more popular and widely used of the adsorbents. However, using 
activated carbon as an adsorbent is not favorable when trying to remove sodium or nitrates since the 
two are not attracted to carbon. In the event that something is not attracted to carbon, it will simply 
pass through without bonding and no removal will occur.  
Ion Exchange Resins 
 With increasing research and development being done on the adsorption of contaminants from 
water, new technologies such as ion exchange resins are rapidly becoming a popular option. They are 
designed with specific attributes to increase their adsorption effectiveness, such as larger pore sizes for 
greater absorbance and greater moisture retention (Purolite, 2013).  Among the many different resins 
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available, all differ slightly by the compounds which they are comprised of and as a result each resin 
removes certain chemicals better than others.   
These resins are split into two main groups, which are anion exchange resins and cation 
exchange resins. Depending if the solution is basic or acidic, a surplus of compounds heavily influenced 
by H+, for acidic solutions, or OH-, for basic solutions, will be adsorbed (Alchin, 2008). Anion exchange 
resins specifically are suggested for the removal of organics as well as many synthetics (Purolite, 2013).  
Purolite is one of the major company brands among the ion exchange resin manufactures. Most 
of the resins are designed as “strong base anion resins”, and with over 40 different resins available, 
suited to extract many different compounds and chemicals, it is clear that Purolite is a widely diverse 
extraction resin. (Purolite, 2013).  
 It is noted among many manufactures of ion exchange resins, such as the Dow Company that 
manufactures a polymeric adsorbent resin, that the resins are affected in many situations by pH, 
temperature, and even ionic strength (Dow, 2013). Resins such as Optipore are more highly suited for 
the removal of organics than chemical compounds. For these resins, it is recommended that equilibrium 
testing takes place in order for the user to understand the amount of time need to prepare the resins for 
use i.e. washing and drying the resins. These resins have larger pore sizes as well, ranging up to a total 
porosity of 1.16 cc/g. 
Amberlite Resins 
A type of ion-exchange resins that have been used to remove contaminants in water are 
Amberlite resins.  Amberlite XAD polymeric adsorbents are ion-exchange resins that remove and recover 
phenols, antibiotics, chlorinated pesticides, various aromatic and nitrogen compounds from aqueous 
streams (Amberlite and Amberlyst Resins).  The specific Amberlite resins XAD-2 and XAD-4 are nonpolar 
and are very effective for narcotics and environmental organic contaminants.  Differently, XAD-7 has 
intermediate polarity and adsorbs phenols from waters from either hydrophobic materials from water 
or hydrophilic materials from non-aqueous systems (Amberlite and Amberlyst Resins).  XAD-4 is a non-
ionic crosslinked polymer, which inherits its adsorbent properties from its patented macroreticular 
structure.  A macroreticular structure means that it contains both a continuous polymer phase and a 
continuous pore phase (Rohm and Haas XAD-4, 2003).  Amberlite XAD-7 also has a macroreticular 
structure, but is a non-ionic aliphatic acrylic polymer (Rohm and Hass XAD-7, 2003). 
 22 
 
Amberlite resins have been used in the adsorption of phenol with the Amberlite XAD-4 being 
able to best remove the phenol from the aqueous solutions (Kujawski et al., 2003).  The adsorption 
process should lower the phenol concentration of the effluent to a level that is acceptable to enter a 
wastewater treatment facility.  This adsorbent was able to remove the phenol model solution by the 
column method.  NAOH solution was the most effective regenerating the sorbent bed because it caused 
the most removal of phenol at low concentrations of the solution (Kujawski et al., 2003). 
 Amberlites have also been found to remove pharmaceuticals from surface waters.  Amberlite 
XAD-7 was used as an adsorbent for removing four different pharmaceuticals that are commonly found 
in surface waters: trimethoprim, carbamazepine, ketoprofren, and naproxen (Dominquez et al., 2011).  
The experiment was carried out at different pH conditions and proved that there was an influence on 
adsorption by pH.  The adsorption capacity decreased for drugs that were more neutral or acidic, but 
increased for the more basic drub, trimethoprim (Dominquez et al., 2011).   
 For pharmaceutical removal, Amberlite resins have been a popular and successful adsorbent 
because it can remove containments from many types of aqueous streams.  The type of Amberlite used 
for each contaminant is very important based on the polarity and whether the contaminant is 
hydrophobic.  Also being a cation exchange resin it will only work as an adsorbent if the exchange is 
from positively charged ions. 
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Chapter 3: Methodology  
3.1 Sample Preparation 
A 1000 mL solution, made from ibuprofen (IBP) received from Sigma Life Science and water 
purified using the Thermo Scientific Barnstead RO NanoPure system, was created with a concentration 
of 15 mg/L. To create this solution, 0.015 g of IBP was weighed using a Mettler Toledo (AB104-S) scale 
and added to 1000 mL of purified water. The solution was stirred thoroughly with a magnetic stirrer for 
a minimum of 24 hours, until a well-mixed solution was achieved with all IBP dissolved. Solutions of 
known initial concentrations were then created from the stock solution for each experimental 
treatment. This was done by pipetting the stock solution into vials with purified water. The pHs of the 
samples were adjusted by the drop-wise addition of NaOH or HCl and the use of an Accumet Basic AB 15 
pH meter (Fisher Scientific). 
3.1.1 Special Sample Preparation 
Amberlite XAD-4 and Amberlite XAD-7 are shipped as a “water wet product” and contain sodium 
chloride (NaCl) and sodium carbonate (Na2CO3) salts to slow and/or inhibit bacteria growth (Rohm and 
Haas, 2003). The salts need to be washed from the amberlites prior to any laboratory use. To wash the 
amerlites of these salts, the absorbents were rinsed thoroughly with purified water and allowed to air 
dry. The other adsorbents (PWA, Filtrasorb 200 GAC, Purolite and Optipore) did not require any special 
sample preparation.  
3.2 Measuring Sample Concentration 
Analysis of the samples of IBP solutions was completed before and after treatment to determine 
the amount of IBP removed during each trial. To complete analysis of each sample, a Varian-Cary 50 
Scan UV – visible spectrophotometer was used with quartz cuvettes to measure the absorbance. The 
spectrophotometer was operated at a wavelength of 223 nm. This wavelength was determined by doing 
a full spectrum scan of several different concentrations of ibuprofen solution.  
3.3 Ibuprofen Concentration Standard Curves with Detection Limit 
In order to determine the unknown concentration of the treated samples, standard 
concentration curves at pH 4, pH 5, and pH 7 were created was samples of solutions at known 
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concentrations. The standard curves were found at these pHs to give a standard curve both below and 
above the pKa of 4.593±0.051 as well as at a neutral pH (Vincenteño et al., 2010). Solutions of ten 
known concentrations of IBP in water, ranging from 0.001 mg/L to 15 mg/L were analyzed by the Varian-
Cary 50 Scan UV – visible spectrophotometer to measure the absorbance. The correlation between the 
known concentration of the sample and the measured absorbance was used to develop the standard 
concentration curve.  
3.4 Adsorption Treatment 
The adsorption treatment experiments were performed to analyze the effect of the type of 
adsorbent and time required for removal. The adsorbents tested were activated carbon, Purolite anion 
exchange resin, and amberlites. Two types of activated carbon were tested. Both the Filtrasorb-200 
granular activated carbon and the PWA powder activated carbon were purchased from Calgon Carbon. 
Two types of amberlites were also tested. Both Amberlite XAD-4 and Amberlite XAD-7 were purchased 
from Sigma Life Science. The final adsorbent was a strong base anion exchange resin, Purolite® A530E, 
purchased from Purolite®. Adsorption was conducted first to equilibrium, and then in time trials. 
Equilibrium occurs when the rate of adsorption equals the rate of desorption and there is no further 
accumulation of IBP on the surface with time. For each experiment, the desired mass of each adsorbent 
was weighed and added to 42 mL glass vials filled with 35 mL of 15 mg/L Ibuprofen solution. Solution 
was added to the vials and securely capped before being placed into a rotisserie mixer to maintain 
uniform motion and mixing as well as adsorption. After treatment, each sample was removed from the 
mixer and filtered using a 0.22 μm syringe filter into quartz spectrophotometer cuvettes for analysis. 
3.4.1 Adsorption Equilibrium Trials 
The equilibrium trials were conducted for 24 hours of contact time to ensure the maximum 
adsorption of IBP. In the equilibrium trials, the type of adsorbent, mass of adsorbent, and pH were 
varied. Trials were conducted at pH 4, pH 5, and pH 7. The initial concentration of IBP in solution was 15 
mg/L for each sample. Various masses of each adsorbent were added to vials of 15 mg/L ibuprofen 
solution for all of the pHs. After mixing for 24 hours, the samples were then analyzed by the 
spectrophotometer to determine the final absorbance. This value was used with the concentration 
standard curve to find the concentration.   
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3.4.2 Adsorption Time Trials – Kinetics 
The time trials were conducted with solutions of an initial concentration of 15 mg/L IBP added 
to vials containing Filtrasorb 200 granular activated carbon, PWA granular activated carbon, Purolite 
A530E, and Amberlite XAD-4. Amberlite XAD-7 did not prove efficient removal in the equilibrium trials 
and therefore was not included in the kinetics trials. Time trials were conducted at intervals of 4 hours 
initially for a period of 24 hours at pH 4 and pH 7. After the initial 24 hours in which samples were tested 
each 4 hours, the increments of time were then determined for further testing to be able to identify 
where equilibrium took place. After each experimental run had been completed, the samples were 
centrifuged and removed from the vials. Once the supernatant was removed, the samples were 
analyzed by the spectrophotometer to determine the final absorbance and concentration. 
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Chapter 4: Results and Discussion 
The objective of this study was to obtain data for the removal of ibuprofen from water using 
adsorption. In total, six adsorbents were investigated: PWA powder activated carbon, Filtrasorb 200 
granular activated carbon, Purolite A530E, Amberlite XAD-4, Amberlite XAD-7 and Optipore L-493. The 
data was analyzed to determine the relative effectiveness of each sorbent in order to make 
recommendations for treatment as well as future research. 
4.1 Calibration Curves 
A calibration curve was established for each tested pH using the UV spectrometer at wavelength 
223 nm to detect ibuprofen after each treatment experiment. The standard curves for each pH are 
plotted in Figure 5 below.  
 
Figure 5: Calibration curves for Ibuprofen in water using Varian Cary UV-vis spectrometer at 223 nm 
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 All standard curves were considered to be an accurate form of detection for ibuprofen 
concentrations below 15 mg/L, with R2 values above 0.98 for pH 4 and above 0.99 for pH 5 and pH 7. 
There is a minor change in slope between each of the lines, which can be attributed to the fact that 
ibuprofen deprotonates after passing through the pKa. Though the pKa is reported to be 4.593±0.051, 
the change is not entirely noticeable until the solution is more basic (Vincenteño et al., 2010). 
4.2 Adsorption Equilibrium Trials 
Equilibrium trials were performed for all of the sorbents to find data on the mass of sorbent 
needed to obtain maximum removal. In the equilibrium trials, the type of adsorbent, mass of adsorbent, 
and pH were varied. Trials were conducted at pH 4, pH 5, and pH 7. After mixing for 24 hours, the 
samples were then analyzed by the spectrophotometer to determine the final absorbance. The data 
below discusses the results found through these equilibrium trials.     
4.2.1 Adsorption Equilibrium Models 
 Adsorption reactions can be described by various adsorption equilibrium models, such as 
empirical models.  These models are isotherms used to describe the equilibrium of adsorption-
desorption reactions because of the complexity of natural systems at a constant temperature.  The 
empirical models are used widely in geochemical applications, especially in transport models of heavy 
metals through soil and groundwater, but the relationship that relates adsorption density to adsorbent 
concentration in aqueous phase at a given temperature is only valid for constant conditions (Hubbard, 
2002).  The most commonly used empirical models are Langmuir isotherm, Freundlich isotherm, and 
Linear isotherm. 
The Langmuir isotherm predicts linear adsorption at low adsorption densities and a maximum 
surface coverage.  This isotherm was developed to describe the adsorption of gases or liquids onto clean 
solids and implies uniform adsorption sites and absence of lateral interactions (Goldberg, 1995).  The 
equation for the Langmuir isotherm is (where a = empirical constant; b = saturation coefficient): 
𝑞𝑒 = 𝑎𝑏𝐶𝑒1+𝑏𝐶𝑒     [Equation 1] 
The empirical constant and saturation coefficient can be determined by plotting the 
experimental data using the linearized equation: 
𝐶𝑒
𝑞𝑒
= 1
𝑎𝑏
+ 𝐶𝑒
𝑎
     [Equation 2] 
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The Freundlich isotherm is valid only for adsorption occurring at a low solution concentration 
(Sposito, 1984).  Unlike the Langmuir equation, the Freundlich isotherm does not predict a maximum 
metal removal on the sorbent surface (Hubbard, 2002).  The equation for the Freundlich isotherm is 
(where KF = Freundlich adsorption; 1/n = intensity of adsorption): 
𝑞𝑒 = 𝐾𝐹𝐶𝑒1 𝑛�      [Equation 3] 
The KF and n are both Freundlich related to the strength of the adsorbent-sorbent interaction 
and to distribution of bond strengths among the surface sites of heterogeneous sorbents.  These 
constants be determined through using experimentally collected data and the plotting the linearization 
of the Freundlich equation: 
log 𝑞𝑒 = log𝐾𝐹 + 1𝑛 log𝐶𝑒     [Equation 4] 
 The Linear isotherm is a special case of the Freundlich isotherm when n =1 and is used for low 
concentrations with a lot of available surface area (Hubbard, 2002).  The equation for the Linear 
isotherm is (where Kd = the binding strength constant): 
𝑞𝑒 = 𝐾𝑑𝐶𝑒      [Equation 5] 
The distribution coefficient, Kd, increases dramatically as metal concentration decreases. 
4.2.2 Filtrasorb 200 Granular Activated Carbon 
The removal of ibuprofen from water was experimented at three different pH values (4,5, and 7) 
using the granular activated carbon Filtrasorb 200.  Only the mass of the Filtrasorb 200 was changed 
keeping the amount of ibuprofen solution constant in each vial.  Isotherms were also generated for 
Filtrasorb 200 at each pH to establish an equilibrium relationship and to analyze the effect of solution pH 
on removal through adsorption. The data was modeled for Langmuir, Freundlich, and Linear isotherms 
and was found to fit best to a Langmuir model.  The results of this equilibrium test and Langmuir 
isotherms data are shown below in Figure 6. 
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Figure 6: Adsorption isotherms for adsorption of ibuprofen on Filtrasorb 200 GAC 
The Filtrasorb 200 is designed to remove dissolved organic compounds from water, such as 
ibuprofen.  As seen above, Filtrasorb 200 was effective overall, but most effective was the pH 4 solution 
for the removal of ibuprofen from the solution.  This does agree with the behavior of Filtrasorb 200 in 
other substances where lower pH values have a higher adsorbance.  All three pH solutions were able to 
achieve a 100 percent removal, therefore it is recommended to use Filtrasorb 200 for removing 
ibuprofen from either acidic or basic solutions. 
4.2.3 PWA Powder Activated Carbon 
The removal of ibuprofen from water was experimented at three different pH values (4, 5, and 
7) using the powdered activated carbon PWA.  Only the mass of the PWA was changed keeping the 
amount of ibuprofen solution constant in each vial.  Isotherms were also generated for PWA at each pH 
to establish an equilibrium relationship and to analyze the effect of solution pH on removal through 
adsorption. The data was modeled for Langmuir, Freundlich, and Linear isotherms and was found to fit 
best to a Langmuir model.  The results of this equilibrium test and the Langmuir isotherms are shown 
below in Figure 7. 
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Figure 7: Adsorption isotherms for adsorption of ibuprofen on PWA Powder Activated Carbon 
As seen in the figure above, PWA’s ability to adsorb the ibuprofen from the solution was 
dependent on the solutions pH.  The PWA was overall effective in the removal of the ibuprofen but was 
most effective as the lower pH value of 4.  This agrees with the design of PWA because it is ideally suited 
for the purifications of pharmaceuticals where the solutions are of a lower pH value.  All three pH 
solutions were able to achieve 100% removal, but as seen in Figure 3 pH was able to achieve this with 
less mass of the adsorbent.  Based on the results it is recommended that PWA Powder Activated Carbon 
be used for removing ibuprofen from acidic solutions. 
4.2.4 Purolite Anion Exchange Resin 
 Using the anion exchange resin Purolite A530E the removal of ibuprofen from water was 
conducted at pH 4, pH 5, and pH 7. Changing only the mass of Purolite A530E added to each vial of 
solution, the adsorption of the ibuprofen from the solution onto the Purolite A530E can be seen below 
in Figure 8.  Isotherms were also generated for Purolite at each pH to establish an equilibrium 
relationship and to analyze the effect of solution pH on removal through adsorption. The data was 
modeled for Langmuir, Freundlich, and Linear isotherms and was found to fit best to a Langmuir model 
based on R2 values. 
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Figure 8: Adsorption isotherms for adsorption of ibuprofen on Purolite A530E 
 Purolite A530E is specifically designed to attract hydrophobic anions, like deprotonated 
ibuprofen. As seen above, Purolite A530E was most effective in the pH 7 solution for the removal of 
ibuprofen from the solution. This is because of Purolite A530E’s “strong base” attraction, as such pH 5 
was the next most efficient and pH 4 follows as the least efficient. Though all three pH solutions were 
able to achieve between 96 to 100 percent removal, it is recommended to use Purolite A530E for 
removing ibuprofen from more basic solutions. 
4.2.5 Amberlite XAD-4 
The removal of ibuprofen using Amberlite XAD-4 as a sorbent was tested at three different pHs 
(pH 4, pH 5 and pH 7) using different masses of the sorbent and keeping both the amount of IBP 
solution, the pH, and the temperature constant. Isotherms were also generated for XAD-4 at each pH to 
establish an equilibrium relationship and to analyze the effect of solution pH on removal through 
adsorption. The data was modeled for Langmuir, Freundlich, and Linear isotherms and was found to fit 
best to a Langmuir model.  The results of this equilibrium test and Langmuir isotherms are shown below 
in Figure 9. 
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Figure 9: Adsorption isotherms for adsorption of ibuprofen on Amberlite XAD-4 
Under the experimental parameters tested, the trial at pH 4 had the highest amount of IBP 
adsorbed and was therefore the most effective at removing ibuprofen at equilibrium. At pH 4, 
ibuprofen is not deprotonated and the charge of the molecule remains neutral. This may be the 
reason for the higher adsorption between Amberlite XAD-4 and IBP at pH 4 considering that 
Amberlite XAD-4 has a non-polar surface and is more likely to form bonds with a non-polar 
contaminant. At pH 4, ibuprofen is neutral in charge because it is the only pH tested below the pKa. 
Since after the pKa at around pH 4.5 ibuprofen starts to deprotonate and develop a charge, 
Amberlite XAD-4 (typically used for neutrally charged compound removal) did not prove as effective 
as it did under the pKa.  
4.2.6 Amberlite XAD-7 
The removal of ibuprofen using Amberlite XAD-7 as a sorbent was tested at three different pHs 
(pH 4, pH 5 and pH 7) using different masses of the sorbent and keeping both the amount of IBP 
solution, the pH, and the temperature constant. Isotherms were also generated for XAD-7 at each pH to 
establish an equilibrium relationship and to analyze the effect of solution pH on removal through 
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adsorption. The data was modeled for Langmuir, Freundlich, and Linear isotherms.  No adsorption 
isotherm model was representative of the equilibrium data observed. Overall the data for the XAD-7 
was ineffective which makes sense with its inability to match an equilibrium adsorption model. The 
results of this equilibrium test and the Freundlich isotherms are shown below in Figure 10. 
 
Figure 10: Adsorption isotherms for adsorption of ibuprofen on Amberlite XAD-7 
As can be seen in Figure 10, pH played an integral role in adsorption of ibuprofen onto 
Amberlite XAD-7. Amberlite XAD-7 was most efficient at pH 4, less efficient at pH 5, and least 
effective at pH 7. Part of this may be that Amberlite XAD-7 is primarily used for the removal of 
larger molecules (Rohm and Haas, 2003). As the pH passes the pKa around pH 4.5, the carboxyl 
group on ibuprofen dissociates and the molecule becomes smaller and more charged. Though 
Amberlite XAD-7 is known to be a good sorbent for polar compounds, the molecular weight of the 
deprotonated ibuprofen may have not been large enough for the XAD-7 to effectively remove. 
4.2.7 Optipore L-493 
Using the polymeric exchange resin Optipore L-493 the removal of Ibuprofen from water was 
conducted at pH 4 and 7. Changing only the amount of Optipore added to each vial of solution, the 
absorbance of the ibuprofen from the solution can be seen below in Figure 11. Isotherms were also 
generated for Optipore at each pH to establish an equilibrium relationship and to analyze the effect of 
solution pH on removal through adsorption. The data was modeled for Langmuir, Freundlich, and Linear 
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isotherms.  Both the Langmuir and Freundlich models fit very well with the Optipore data with the R2 
values being slightly better for the Freundlich model. 
 
Figure 11: Adsorption isotherms for adsorption of ibuprofen on Optipore L-493 
Optipore L-493 is designed for use in aqueous solutions and with its large total pore volume, 
roughly 1.16 cc/g, it has the ability to adsorb more than most other resins (Dow Chemical Company, 
2013).  It is noted in the MSDS for Optipore L-493 that the adsorption forces are highly dependent on pH 
and it is recommended to screen the product when applying it for specific uses. As seen above, the pH 4 
solution was the most efficient at the removal of ibuprofen. Between the two pHs tested, the solutions 
achieved between 96-99% removal and is considered to be a competent removal agent. It is 
recommended that Optipore L-493 be used in more acidic solutions. 
4.2.8 Comparison of Adsorbents 
 Various different masses of each adsorbent were tested to create the isotherms presented in 
this paper. The purpose of testing the different masses was to determine the smallest mass that would 
yield the best removal of ibuprofen. The adsorbents were looked at “qe” versus the concentration at 
equilibrium. The term “qe” represents a ratio of the mass absorbed to the mass of the sorbent in the 
sample. The figure below shows all of the adsorbents at pH 4 plotted together. As can be seen, PWA 
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powdered activated carbon has the best removal with the best mass adsorbed to mass of adsorbent 
ratio.  
 
Figure 12: Adsorption isotherms for adsorption of ibuprofen onto all adsorbents at pH 4 
Filtrasorb 200 GAC also has an exceptional mass adsorbed to mass of adsorbent ratio for pH 4. The 
figure above shows that other than PWA, the other adsorbents are comparable at pH 4. This is because 
all of the adsorbents had similar successes at pH 4.  
 At pH 7, as can be seen in the figure below, the results were different. Both PWA and Purolite 
A530E were competitive with the removal when looking at the ratio of mass ibuprofen adsorbed to 
mass of the adsorbent. Purolite A530E outperforms Filtrasorb 200 GAC at pH 7 as well.  
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Figure 13: Adsorption isotherms for adsorption of ibuprofen onto all adsorbents at pH 7 
Purolite A530E’s exceptional removal at pH 7 is very likely due to the fact that it is a strong base 
anion exchange resin and is designed to perform best is more basic solutions. Currently, activated 
carbon is the most common adsorbent. It is important to see that Purolite A530E is competitive in 
removal of ibuprofen with PWA and outperforms Filtrasorb 200 GAC. This discovery could prove to be 
very useful in the future of treating pharmaceuticals in drinking water. This is because groundwaters and 
surface waters are closer to pH 7 than pH 4. Also, it is important to note that Purolite A530E’s physical 
properties allow it to settle on its own as opposed to PWA, which needs to be filtered out.  
4.3 Adsorption Time Trials 
The time trials were conducted for Filtrasorb 200 granular activated carbon, PWA powder 
activated carbon, Purolite A530E, Optipore and Amberlite XAD-4. Amberlite XAD-7 did not prove 
efficient removal in the equilibrium trials and therefore was not included in the kinetics trials. Time trials 
were conducted at intervals of 4 hours initially for a period of 24 hours at pH 4 and pH 7. The time trials 
did not include pH 5, as it was concluded that it was too close to the pKa to prove substantial results in 
either direction and results for pH 4 and pH 7 were good representatives for below and above the pKa. 
After the initial 24 hours in which samples were tested each 4 hours, the increments of time were then 
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determined for further testing to be able to identify where equilibrium took place. After each 
experimental run had been completed, the samples were filtered with syringe filters and tested using 
the spectrophotometer to determine the concentration. This section discusses the results found during 
the adsorption time trials.  
4.3.1 Filtrasorb 200 Granular Activated Carbon 
The timed trial of the removal of ibuprofen from water using the granular activated carbon 
Filtrasorb 200 was conducted at pH 4 with 0.02g of adsorbent and at pH 7 with 0.075g of adsorbent.  
These masses were chosen based on the smallest amount of adsorbent to reach around 98% removal.  
The results of this time test are shown below in Figure 14. 
 
Figure 14: Adsorption Time Trials for Ibuprofen on Filtrasorb 200 GAC 
As can be seen in the figures above, equilibrium took place within the first 4 hours after being 
put in the rotisserie mixer for the pH 7 solution.  Further tests then showed that Filtrasorb 200 reached 
removal equilibrium around 3.5 hours.  For the pH 4 solution, equilibrium took place around the 15 
hours.  With Filtrasorb 200’s common usage in wastewater and drinking water removal it makes sense 
that the adsorbent reaches removal equilibrium in a fairly quick manor for the pH 7 solution.  With 
water typically being around pH 7 the Filtrasorb 200 would need to be able to remove contaminants as 
0
2
4
6
8
10
12
14
0 5 10 15 20 25
Co
nc
en
tr
at
io
n 
at
 t 
(m
g/
L)
 
Time (hours) 
pH 4, 0.02g
pH 7, 0.075g
 38 
 
quickly as possible.  Having to increase and decrease the pH of the water before treatment is neither 
time nor cost efficient.      
4.3.2 PWA Powder Activated Carbon 
The timed trial of the removal of ibuprofen from water using the PWA Activated Carbon was 
conducted at pH 4 with 0.005g of adsorbent and at pH 7 with 0.05g of adsorbent.  These masses were 
chosen based on the smallest amount of adsorbent to reach around 98% removal.  The results of this 
time test are shown below in Figure 15. 
 
Figure 15: Adsorption Time Trials for ibuprofen on PWA Activated Carbon 
As can be seen in Figure 15, equilibrium took place within the first 4 hours after being put in the 
rotisserie mixer for the both the pH 4 and pH 7 solution.  Further tests then showed that PWA Activated 
Carbon reached removal equilibrium around 4 hours.   
4.3.3 Purolite Anion Exchange Resin 
The time trial for the removal of ibuprofen using Purolite A530E was conducted at pH 4 with 
0.025g of adsorbent in the solution and at pH 7 with 0.1g of adsorbent. The masses were determined 
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based on which amounts would yield the highest removal percentage (99-100%) while using the 
smallest amount of that sorbent as possible. The results of the time trial are shown below in Figure 16. 
 
Figure 16: Adsorption Time Trials for Ibuprofen on Purolite A530E 
 As seen above, the pH 4 solution achieved equilibrium between 3.5 and 4 hours of mixing 
reaching a removal percentage of 96-98%. The pH 7 solution achieved equilibrium roughly around the 
same time with a removal percentage 95-97%. For usage in water purification, Purolite is a promising 
adsorbent due to the quickness in which it reaches equilibrium.  
4.3.4 Amberlite XAD-4 
The timed trial of the removal of ibuprofen from water using Amberlite XAD-4 ion exchange 
resin was conducted at pH 4 with 0.1 g of adsorbent and at pH 7 with 0.025 g of adsorbent.  The mass 
for pH 4 was selected based on the smallest mass of adsorbent with an acceptable removal, which in 
this case was 98.3% removal. The mass for pH 7 was selected based on the highest percent removal 
obtained through the equilibrium trials. For pH 7, a mass of 2.0 g resulted in a removal of 59.3% 
removal, which was the highest removal reached for Amberlite XAD-4 at pH 7. The results for these time 
trials are below in Figure 17. 
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Figure 17: Adsorption Time Trials for ibuprofen on Amberlite XAD-4 
Figure 17, above, shows the concentration for pH 7 reaching equilibrium by four hours with a 
concentration of equilibrium averaging to approximately 12.2 mg/L. This proves less removal than was 
initially founded in the equilibrium trial in which 2.0 g resulted in a concentration at equilibrium at 6.09 
mg/L. There could be several explanations for this such as lab error. Since the Amberlite XAD-4 and 
Amberlite XAD-7 both needed to be washed before use, the adsorbents were washed on an as-needed 
basis depending on the mass required for testing. The samples from the equilibrium trials were not 
washed in the same batch as the amberlites for the kinetics trials. Therefore, the sorbents may not have 
been washed as thoroughly as they were the first time. Another potential explanation could be the 
amount of Amberlite XAD-4 that made it into the vial for the testing. The resins would bounce off of the 
aluminum measuring tins, which they were weighed on, as the resins were being poured into the vials. 
Sometimes negligible amounts of the resin were lost in this process. Either of these could contribute to 
the discrepancy in results between the equilibrium trials and the time trials for Amberlite XAD-4.  
Similarly, the pH 4 for Amberlite XAD-4 proved to reach equilibrium around four hours. After four hours, 
the concentration at equilibrium averaged to approximately 0.26 mg/L, which is a 98.2% removal of 
ibuprofen from the water. The time trial for pH 4, as seen above in Figure 17, reaches equilibrium in the 
first four hours on contact time. Within one hour, the concentration of ibuprofen is already down to 
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5.28 mg/L which is a removal of 64.8% removal. Removal reaches 90.5% at three hours of contact time, 
with a concentration of ibuprofen being 1.43 mg/L.  
4.3.5 Optipore L-493 
The time trial removal of ibuprofen from water using the polymeric resin Optipore L-493 was 
conducted at pH 4 with 0.1g of adsorbent and at pH 7 with 0.2g of adsorbent.  These masses were 
chosen based on the smallest amount of adsorbent that is needed to reach roughly 99% removal. The 
results of this time test are shown below in Figure 18. 
 
Figure 18: Adsorption Time Trial for Ibuprofen on Optipore L-493 
 The pH 4 solution achieved a removal percentage of roughly 97% around hour 8-9, and similarly 
the pH 7 solution achieved a removal percentage of 97% around hour 10. Both worked very well in 
regards to the total removal of the ibuprofen, as descripted before in the equilibrium results. In respect 
to time however, the Optipore did not perform as quickly as some of the other sorbents. 
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4.3.6 Comparison of Adsorbents 
In the time trials, all of the adsorbents proved to reach equilibrium within 24 hours. Below, in 
Figure 19, are the results for all of the adsorbents at pH 4 plotted together. The Filtrasorb 200 did not 
reach equilibrium until approximately 12 hours. The adsorbents that proved the best removal were 
Amberlite XAD-4 and PWA activated carbon. Of these two, PWA activated carbon reached equilibrium 
the fastest, reaching a concentration of 0.15 mg/L in only one hour. This can be explained by the fact 
that powdered activated carbon has a large available surface area as well as adsorption capacity (Serpa 
et al., 2005).  
 
Figure 19: Adsorption Time Trials at pH 4 
Most of the adsorbents reach equilibrium by eight hours, with the exception of Filtrasorb 200 
granular activated carbon. The Filtrasorb 200 GAC did reach equilibrium at 12 hours. Within eight hours, 
all of the adsorbents are below 0.6 mg/L, which is representative of 95.9% removal of ibuprofen. The 
second best adsorbent for pH 4 was Amberlite XAD-4. This can be explained by the fact that the surface 
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area of Amberlite XAD-4 is ≥750 m2/g (Rohm and Haas, 2003). This is not far behind PWA powdered 
activated carbon’s surface area of 900-1000 m2/g (Calgon Carbon Corporation, 2008). Surface area and 
pore size have a large effect of the adsorbance of ibuprofen on the different adsorbents.  
 In the time trials, all of the adsorbents proved to reach equilibrium within 24 hours. Below, in 
Figure 20, are the results for all of the adsorbents at pH 7 plotted together. As discussed previously, 
Amberlite XAD-4 did not prove effective removal at pH 7. Like pH 4, PWA powdered activated carbon 
proved the best removal overall at pH 7, which showed 98.6% removal as its worst. Once again, as 
expressed earlier PWA has a large amount of surface area in which to adsorb the ibuprofen. This has 
proved to make PWA powdered activated carbon the best performing adsorbent regardless of pH.  
Filtrasorb 200 granular activated carbon, Optipore L-493, and Purolite A530E all proved acceptable 
removal as well.  
 
Figure 20: Adsorption Time Trials at pH 7 
Filtrasorb 200 granular activated carbon, Optipore L-493, and Purolite A530E all were very 
similar in removals as can be seen in Figure 20. Filtrasorb 200 reached equilibrium soon after PWA 
powdered activated carbon and showed more than 98% removal by four hours into the time trials. Both 
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PWA and Filtrasorb 200 were the top performing adsorbents. This is very much the reason why 
activated carbons are used so widely in the water treatment and wastewater treatment industries, in 
addition to air purification and odor control. Figure 20 shows that while PWA and Filtrasorb 200 were 
the two top performing adsorbents, Purolite A530E and Optipore L-493 were not far behind. Both 
Purolite A530E and Optipore L-493 reached 96% removal by 16 hours into the time trial.  
PWA powdered activated carbon, Filtrasorb 200 granular activated carbon, Purolite A530E, and 
Optipore L-493 would all be acceptable adsorbents for ibuprofen removal at pH 7 in the event that 
contact time was not a limiting factor. If contact time was a priority, the best option would clearly be 
PWA powdered activated carbon.  
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Chapter 5: Conclusions and Recommendations 
The purpose of this project was to investigate the treatability of ibuprofen in drinking water using 
adsorption methods.  Six different adsorbents were tested using batch adsorption in both equilibrium 
experiments and time trials. Overall, four adsorbents were successful in the removal of ibuprofen for 
both pHs. These adsorbents were PWA powdered activated carbon, Filtrasorb 200 granular activated 
carbon, Purolite A530E, and Optipore L-493. For both pH 4 and 7, these four adsorbents reached 96% 
removal within the equilibrium period. In terms of all of the adsorbents, pH 4 had more general success 
with five out of six adsorbents reaching high percentages of removal. However, pH 7 had higher 
percentage removal in a shorter contact time but with fewer adsorbents reaching those levels. Out of all 
of the experiments PWA powdered activated carbon at pH 7 proved to be the most effective in the 
removal of ibuprofen from water. PWA powdered activated carbon reached 98.6% removal within one 
hour of contact time for pH 4 and 99.7% removal within one hour of contact time for pH 7 making it the 
most successful adsorbent tested in these trials.  
Despite PWA powdered activated carbon’s successful results, the physical nature of the adsorbent 
could be problematic for certain treatment applications. The fine grained nature of PWA makes it 
difficult to settle out of aqueous solutions. For the sake of this project, aqueous solutions containing 
PWA needed to be filtered using a 0.22µm syringe filter. This was successful in removing the PWA from 
the solution, however would not be feasible for large volumes or constant flow. With these conclusions 
about PWA powdered activated carbon, it is recommended to look further at Purolite A530E. In the 
comparison of the adsorbents at equilibrium focusing on the ratio of ibuprofen adsorbed from the 
solution to the mass of adsorbent used, Purolite A530E was comparable in the removal of ibuprofen 
from water at pH 7. Though this adsorbent does not have the short contact time that is observed with 
PWA, its physical properties allow it to settle out of aqueous solutions on its own. Since streams and 
groundwater typically range from pH 6.5 and 8.5 and natural water ranges from pH 5 to 8.5, Purolite 
A530E would be a desirable choice (Purdue University, 2013).  
In order to make a more definitive recommendation, it is suggested that more research be done to 
determine the most viable treatment method. For example, the costs of each adsorbent would need to 
be factored into the decision. This not only includes the cost of the physical adsorbents, but also the 
costs of storage, disposal, in addition to the cost of adjusting the pH if necessary. In addition to the 
financial costs associated with treatment, it is also suggested that there be more research into the 
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ability to recycle adsorbents. To recycle the adsorbents, the ibuprofen and other contaminants adsorbed 
would need to be taken off of the adsorbent and then it could be re-used. This is something that would 
help reduce costs. Other considerations for further research would include looking into potential 
catalysts to reduce contact time for the different adsorbents as well as looking into powdered activated 
carbon flocs (PACF), which are claimed to have similar effectiveness without the settling problems 
observed with the PWA powdered activated carbon trials.  
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Chapter 6: Engineering Design – Activated Carbon Contactor  
Problem Statement 
A municipal drinking water treatment plant is finding noticeable amount of ibuprofen (IBP) in their 
drinking water source. The current concentration detected is about 4 µg/L. A possible explanation for 
this is that the local wastewater treatment facility has a substantial flow coming from a nearby nursing 
home. There are thoughts that the nursing home might be flushing excess drugs, in addition to the 
amount of IBP that may be passing through patients’ digestive systems. After publishing this information 
in the report sent to all of the clients, there were several complaints about having such a high amount of 
ibuprofen in the water. The drinking water treatment facility decided to add in a process to remove the 
ibuprofen. The drinking water treatment facility decided to add a granular activated carbon contactor to 
remove the ibuprofen, because it is cost effective and would also help in the removal of some organic 
compounds that could pass through other treatment processes.  
The Treatment Facility Processes 
The Municipal Drinking Water Treatment Facility has the following system, with the addition of 
the activated carbon contactor coming after filtration but before the water goes to storage.  
 
The Design 
 There will be 3 contactors, with two running in series and one offline for redundancy to help 
with maintenance. The following steps are in order to design one single GAC contactor column.  
Bed Life Design 
 The design was determined using the Bed Life Design approach. Equation 7, below, observes the 
volume of fluid passing through a contactor needed for complete saturation of the column. The design is 
using Calgon Corporation’s Filtrasorb 200 GAC and therefore was designed to an experimental “qe” 
found earlier in this paper. Filtrasorb 200 GAC was best modeled by the Langmuir isotherm model. 
Equation 6 below shows the relationship for qe for Langmuir isotherms.  
Reservoir Screen Aeration Tank Rapid Mix Slow Mix 
Settling 
Tank Filter 
Activated 
Carbon 
Contactor 
Storage 
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𝑞𝑒 = 𝑎∙𝑏∙𝐶𝑒1+𝑏∙𝐶𝑒       [Equation 6] 
The "a” and “b” variables were found earlier in this paper for the isotherms in the Results & Discussion. 
Ce is 0.04 mg/L.  For the experimental data found at pH 7, “a” was found to be 0.039349 and “b” was 
found to be 1.1787.  
𝑞𝑒 = 0.039349 ∙ 1.1787 ∙ 0.04𝑚𝑔𝐿1 + 1.1787 ∙ 0.04𝑚𝑔𝐿  
𝑞𝑒 = 0.00169 
 
The following Equation shows will solve for the volume of granular activated carbon needed. The density 
of Filtrasorb 200 GAC was also needed for this equation. The ρGAC for Filtrasorb 200 is 0.58 g/mL 
(Calgon Carbon, 2012). 
𝑉𝑓𝑙𝑢𝑖𝑑
𝑉𝐺𝐴𝐶
= 𝑞𝑒𝜌𝐺𝐴𝐶
𝐶0
    [Equation 7] 
The Vfluid can also be expressed (as seen in Equation 8). 
𝑉𝑓𝑙𝑢𝑖𝑑 = 𝑄 � 𝑚3ℎ𝑜𝑢𝑟� ∙ 𝑇 (ℎ𝑜𝑢𝑟𝑠)   [Equation 8] 
Combining the two equations above, Equation 9 can be formed. 
𝑄 ∙𝑇 
𝑉𝐺𝐴𝐶 = 𝑞𝑒𝜌𝐺𝐴𝐶𝐶0     [Equation 9] 
 Several of the parameters in Equation 9 are already defined, such as Q, VGAC, qe, ρGAC and C0. The 
facility is being designed for a flowrate, Q, of 2 MGD or 315.45 m3 per hour. The “qe” solved for was 
0.00169. The time until the activated carbon reaches complete saturation, T, was chosen to be 180 days 
(about 6 months). The C0, stated in the problem statement, is 4 μg/L. Inputting these parameters into 
Equation 9 produces the equation below. 
315.45𝑚3
ℎ𝑟
∙ 4320 ℎ𝑟 
𝑉𝐺𝐴𝐶 = 0.00169∙580𝑔𝐿0.000004 𝑔/𝐿  
𝑉𝐺𝐴𝐶 =   5.56 𝑚3 
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Contactor Sizing 
 The next step in the design was to size the GAC contactor columns. The important factors in 
sizing the column were surface area and volume. The volume needed to be able to hold the VGAC and the 
surface area needed to be able to provide a reasonable linear velocity when using Equation 5. 
𝐿𝑖𝑛𝑒𝑎𝑟 𝑉𝑒𝑙𝑜𝑐𝑖𝑡𝑦 �𝑚
ℎ
� =  𝑄 �𝑚3ℎ𝑟 �
𝑆𝐴 (𝑚2)   [Equation 10] 
A reasonable linear velocity is between 5 to 20 meters per hour (Creek et al., 2013). The design assumed 
a cylindrical column, and therefore the volume was calculated using the general equation for volume of 
a cylinder, as can be seen in Equation 6 and the surface area for the column was calculated using 
Equation 12.  
𝑉𝑐𝑦𝑙𝑖𝑛𝑑𝑒𝑟 = 𝜋 ∙ 𝑟2 ∙ ℎ   [Equation 11] 
𝑆𝐴𝑐𝑦𝑙𝑖𝑛𝑑𝑒𝑟 = 𝜋 ∙ 𝑟2   [Equation 12] 
Trial and error was used to size the column. In order to keep a reasonable linear velocity, the column 
needed a larger surface area. A height of 0.6 meters and a radius of 2 meters were chosen for the 
column. This calculated for a surface area of12.57 m2 and a volume of7.54 m3. This volume allows for 
some void space. The optimal linear velocity is 6 gallons per minute per ft2, which is 17.64 m/h (Creek et 
al., 2013). The linear velocity calculated with these parameters is 25.10 m/h, which is close to the 
optimal velocity.  
Design Schematics 
 As a result of the previous calculation, below are the design parameters for this activated carbon 
contactor. The contactor will be able to treat 4 µg/L of ibuprofen. The activated carbon will be 
completely saturated after 180 days.  
Table 1 shows the physical design parameters that are needed to fulfill the requirements for this system.  
Table 1: GAC Contactor Physical Parameters 
Height Radius Volume Surface Area 
Linear 
Velocity 
GAC Bed 
Depth 
(m) (m) (m3) (m2) m/h m 
0.6 2.00 7.54 12.57 25.10 0.4425 
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Below are diagrams of the design with the dimensions calculated for this contactor. 
 
 
Figure 21: Contactor Dimensions 
 With all of the contactors able to run in series, the system will look like the figure below. There 
would only be two contactors running at any given time. The third contactor is to allow to switch which 
contactors are running. This makes it easier to perform maintenance if needed and to ensure that not all 
of the GAC beds will be complete saturated at the same time. There are valves throughout the system to 
close off different pipes. These valves allow for the bypass of any individual contactor. As a result, 
influent could run through Column 1, and if V-2 and V-3 are closed, then proceed to Column 3, bypassing 
Column 2.   
 51 
 
 
Figure 22: Granular Activated Carbon Contactor System 
In addition, there is a backwash system for the cleaning of the contactor system. The pipelines for the 
backwash system are shown in Figure 23. 
 
Figure 23: Granular Activated Carbon Contactor System with Backwash 
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Appendix A: Equilibrium Data 
Filtrasorb 200 GAC 
  0.0075 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.2961 6.66891892 55.5405405 0.03887838 
  0.3091 6.96171171 53.5885886 0.03751201 
Ave: 0.3026 6.81531532 54.5645646 0.0381952 
pH 5 0.2300 5.26315789 64.9122807 0.0454386 
  0.2363 5.40732265 63.9511823 0.04476583 
Ave: 0.23315 5.33524027 64.4317315 0.04510221 
pH 7 0.2685 5.78663793 61.4224138 0.04299569 
  0.2767 5.96336207 60.2442529 0.04217098 
Ave: 0.2726 5.875 60.8333333 0.04258333 
      0.01 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0894 2.01351351 86.5765766 0.0454527 
  0.087 1.95945946 86.9369369 0.04564189 
Ave: 0.0882 1.98648649 86.7567568 0.0455473 
pH 5 0.2415 5.52631579 63.1578947 0.03315789 
  0.2401 5.49427918 63.3714722 0.03327002 
Ave: 0.2408 5.51029748 63.2646834 0.03321396 
pH 7 0.2904 6.25862069 58.2758621 0.03059483 
  0.2844 6.12931034 59.137931 0.03104741 
Ave: 0.2874 6.19396552 58.7068966 0.03082112 
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      0.02 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0017 0.03828829 99.7447447 0.026183 
  0.002 0.04504505 99.6996997 0.02617117 
Ave: 0.00185 0.04166667 99.7222222 0.02617708 
pH 5 0.0665 1.52173913 89.8550725 0.02358696 
  0.0697 1.59496568 89.3668955 0.02345881 
Ave: 0.0681 1.5583524 89.610984 0.02352288 
pH 7 0.1061 2.28663793 84.7557471 0.02224838 
  0.1046 2.25431034 84.9712644 0.02230496 
Ave: 0.10535 2.27047414 84.8635057 0.02227667 
      0.03 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0 0 100 0.0175 
  0 0 100 0.0175 
Ave: 0 0 100 0.0175 
pH 5 0.0159 0.36384439 97.5743707 0.01707551 
  0.0141 0.32265446 97.8489703 0.01712357 
Ave: 0.015 0.34324943 97.7116705 0.01709954 
pH 7 0.0332 0.71551724 95.2298851 0.01666523 
  0.0334 0.71982759 95.2011494 0.0166602 
Ave: 0.0333 0.71767241 95.2155172 0.01666272 
      0.04 
  Abs Ce (mg/L) % Removal Qe (mg) 
pH 4 0 0 100 0.013125 
  0 0 100 0.013125 
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Ave: 0 0 100 0.013125 
pH 5 0.0062 0.14187643 99.0541571 0.01300086 
  0.0043 0.09839817 99.3440122 0.0130389 
Ave: 0.00525 0.1201373 99.1990847 0.01301988 
pH 7 0.0083 0.17887931 98.8074713 0.01296848 
  0.0102 0.21982759 98.5344828 0.01293265 
Ave: 0.00925 0.19935345 98.670977 0.01295057 
      0.05 
  Abs Ce (mg/L) % Removal Qe  
pH 4 0 0 100 0.0105 
  0 0 100 0.0105 
Ave: 0 0 100 0.0105 
pH 5 0.0011 0.02517162 99.8321892 0.01048238 
  0.0028 0.06407323 99.5728452 0.01045515 
Ave: 0.00195 0.04462243 99.7025172 0.01046876 
pH 7 0.0156 0.3362069 97.7586207 0.01026466 
  0.0167 0.35991379 97.6005747 0.01024806 
Ave: 0.01615 0.34806034 97.6795977 0.01025636 
 
 
 
 
      0.075 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0 0 100 0.007 
  0 0 100 0.007 
Ave: 0 0 100 0.007 
pH 5 0.0007 0.01601831 99.8932113 0.00699252 
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  0.0028 0.06407323 99.5728452 0.0069701 
Ave: 0.00175 0.04004577 99.7330282 0.00698131 
pH 7 0.0144 0.31034483 97.9310345 0.00685517 
  0.0132 0.28448276 98.1034483 0.00686724 
Ave: 0.0138 0.29741379 98.0172414 0.00686121 
      0.1 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0 0 100 0.00525 
  0 0 100 0.00525 
Ave: 0 0 100 0.00525 
pH 5 0 0 100 0.00525 
  0 0 100 0.00525 
Ave: 0 0 100 0.00525 
pH 7 0 0 100 0.00525 
  0 0 100 0.00525 
Ave: 0 0 100 0.00525 
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PWA Powdered Activated Carbon 
  0.0007 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.3255 7.331081081 51.1261261 0.38344595 
  0.3387 7.628378378 49.1441441 0.36858108 
Ave: 0.3321 7.47972973 50.1351351 0.37601351 
pH 5 0.3324 7.606407323 49.2906178 0.36967963 
  0.3671 8.400457666 43.9969489 0.32997712 
Ave: 0.34975 8.003432494 46.6437834 0.34982838 
pH 7 0.5037 10.85560345 27.6293103 0.20721983 
  0.5198 11.20258621 25.316092 0.18987069 
Ave: 0.51175 11.02909483 26.4727011 0.19854526 
      0.001 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.2601 5.858108108 60.9459459 0.31996622 
  0.2645 5.957207207 60.2852853 0.31649775 
Ave: 0.2623 5.907657658 60.6156156 0.31823198 
pH 5 0.3065 7.013729977 53.2418002 0.27951945 
  0.3179 7.274599542 51.5026697 0.27038902 
Ave: 0.3122 7.14416476 52.3722349 0.27495423 
pH 7 0.3832 8.25862069 44.9425287 0.23594828 
  0.3925 8.459051724 43.6063218 0.22893319 
Ave: 0.38785 8.358836207 44.2744253 0.23244073 
      0.002 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.1036 2.333333333 84.4444444 0.22166667 
  0.1072 2.414414414 83.9039039 0.22024775 
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Ave: 0.1054 2.373873874 84.1741742 0.22095721 
pH 5 0.3536 8.091533181 46.0564455 0.12089817 
  0.3489 7.983981693 46.7734554 0.12278032 
Ave: 0.35125 8.037757437 46.4149504 0.12183924 
pH 7 0.4233 9.122844828 39.1810345 0.10285022 
  0.4391 9.463362069 36.9109195 0.09689116 
Ave: 0.4312 9.293103448 38.045977 0.09987069 
 
 
 
 
      0.0025 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0506 1.13963964 92.4024024 0.19404505 
  0.0496 1.117117117 92.5525526 0.19436036 
Ave: 0.0501 1.128378378 92.4774775 0.1942027 
pH 5 0.3018 6.90617849 53.9588101 0.1133135 
  0.3135 7.173913043 52.173913 0.10956522 
Ave: 0.30765 7.040045767 53.0663616 0.11143936 
pH 7 0.3852 8.301724138 44.6551724 0.09377586 
  0.4022 8.668103448 42.2126437 0.08864655 
Ave: 0.3937 8.484913793 43.433908 0.09121121 
      0.003 
  
0.003g 
(Abs) 
Ce (mg/L) % Removal Qe (mg) 
pH 4 0.0075 0.168918919 98.8738739 0.17302928 
  0.0083 0.186936937 98.7537538 0.17281907 
Ave: 0.0079 0.177927928 98.8138138 0.17292417 
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pH 5 0.2519 5.764302059 61.5713196 0.10774981 
  0.2642 6.04576659 59.6948894 0.10446606 
Ave: 0.25805 5.905034325 60.6331045 0.10610793 
pH 7 0.2004 4.318965517 71.2068966 0.12461207 
  0.1988 4.284482759 71.4367816 0.12501437 
Ave: 0.1996 4.301724138 71.3218391 0.12481322 
      0.004 
  
0.004 g 
(Abs) 
Ce (mg/L) % Removal Qe  
pH 4 0.0061 0.137387387 99.0840841 0.13004786 
  0.0065 0.146396396 99.024024 0.12996903 
Ave: 0.0063 0.141891892 99.0540541 0.13000845 
pH 5 0.1723 3.942791762 73.7147216 0.09675057 
  0.1733 3.965675057 73.5621663 0.09655034 
Ave: 0.1728 3.95423341 73.6384439 0.09665046 
pH 7 0.1851 3.989224138 73.4051724 0.09634429 
  0.1793 3.864224138 74.2385057 0.09743804 
Ave: 0.1822 3.926724138 73.8218391 0.09689116 
 
 
 
 
 
      0.005 
  
0.005 g 
(Abs) 
Ce (mg/L) % Removal Qe 
pH 4 0.0159 0.358108108 97.6126126 0.10249324 
  0.0125 0.281531532 98.1231231 0.10302928 
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Ave: 0.0142 0.31981982 97.8678679 0.10276126 
pH 5 0.0894 2.04576659 86.3615561 0.09067963 
  0.0788 1.803203661 87.9786423 0.09237757 
Ave: 0.0841 1.924485126 87.1700992 0.0915286 
pH 7 0.24 5.172413793 65.5172414 0.0687931 
          
Ave: 0.24 5.172413793 65.5172414 0.0687931 
      0.0075 
  Abs Ce (mg/L) % Removal Qe 
pH 4 -0.0048 -0.108108108 100.720721 0.0705045 
  -0.0058 -0.130630631 100.870871 0.07060961 
Ave: -0.0053 -0.119369369 100.795796 0.07055706 
pH 5 0.0641 1.466819222 90.2212052 0.06315484 
  0.0834 1.908466819 87.2768879 0.06109382 
Ave: 0.07375 1.687643021 88.7490465 0.06212433 
pH 7 0.1256 2.706896552 81.954023 0.05736782 
  0.1312 2.827586207 81.1494253 0.0568046 
Ave: 0.1284 2.767241379 81.5517241 0.05708621 
      0.05
  
0.05 g 
(Abs) 
Ce (mg/L) % Removal Qe (mg) 
pH 4 0.0027 0.060810811 99.5945946 0.01045743 
  0.005 0.112612613 99.2492492 0.01042117 
Ave: 0.00385 0.086711712 99.4219219 0.0104393 
pH 5 0.0097 0.221967963 98.5202136 0.01034462 
  0.0056 0.128146453 99.1456903 0.0104103 
Ave: 0.00765 0.175057208 98.8329519 0.01037746 
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pH 7 0.0161 0.346982759 97.6867816 0.01025711 
  0.0122 0.262931034 98.2471264 0.01031595 
Ave: 0.01415 0.304956897 97.966954 0.01028653 
 
 
 
 
 
 
      0.1 
  0.1 g (Abs) Ce (mg/L) % Removal Qe (mg) 
pH 4 0.0006 0.013513514 99.9099099 0.00524527 
  -0.001 -0.022522523 100.15015 0.00525788 
Ave: -0.0002 -0.004504505 100.03003 0.00525158 
pH 5 -0.0046 -0.105263158 100.701754 0.00528684 
  -0.0017 -0.038901602 100.259344 0.00526362 
Ave: -0.00315 -0.07208238 100.480549 0.00527523 
pH 7 -0.0015 -0.032327586 100.215517 0.00526131 
  -0.0022 -0.047413793 100.316092 0.00526659 
Ave: -0.00185 -0.03987069 100.265805 0.00526395 
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Purolite A530E 
  0.001 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.4091 9.513953488 36.57364341 0.19201163 
  0.4169 9.695348837 35.36434109 0.18566279 
Ave: 0.413 9.604651163 35.96899225 0.18883721 
pH 5 0.4639 10.56719818 29.55201215 0.15514806 
  0.4634 10.55580866 29.62794229 0.1555467 
Ave: 0.4637 10.56150342 29.58997722 0.15534738 
pH 7 0.4503 9.642398287 35.71734475 0.18751606 
  0.4536 9.713062099 35.24625268 0.18504283 
Ave: 0.45195 9.677730193 35.48179872 0.18627944 
      0.003 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.2613 6.076744186 59.48837209 0.10410465 
  0.2677 6.225581395 58.49612403 0.10236822 
Ave: 0.2645 6.151162791 58.99224806 0.10323643 
pH 5 0.2487 5.665148064 62.23234624 0.10890661 
  0.2357 5.369020501 64.20652999 0.11236143 
Ave: 0.2422 5.517084282 63.21943812 0.11063402 
pH 7 0.2222 4.758029979 68.27980014 0.11948965 
  0.2236 4.788008565 68.0799429 0.1191399 
Ave: 0.2229 4.773019272 68.17987152 0.11931478 
      0.005 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.2161 5.025581395 66.49612403 0.06982093 
  0.217 5.046511628 66.35658915 0.06967442 
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Ave: 0.21655 5.036046512 66.42635659 0.06974767 
pH 5 0.1468 3.343963554 77.70690964 0.08159226 
  0.1517 3.455580866 76.96279423 0.08081093 
Ave: 0.1493 3.39977221 77.33485194 0.08120159 
pH 7 0.109 2.334047109 84.43968594 0.08866167 
  0.1007 2.156316916 85.62455389 0.08990578 
Ave: 0.10485 2.245182013 85.03211991 0.08928373 
 
 
 
 
      0.0075 
  Abs Ce(mg/L) % Removal Qe 
pH 4 0.1653 3.844186047 74.37209302 0.05206047 
  0.1688 3.925581395 73.82945736 0.05168062 
Ave: 0.16705 3.884883721 74.10077519 0.05187054 
pH 5 0.0912 2.077448747 86.15034169 0.06030524 
  0.0959 2.184510251 85.43659833 0.05980562 
Ave: 0.0936 2.130979499 85.79347001 0.06005543 
pH 7 0.0874 1.871520343 87.52319772 0.06126624 
  0.0868 1.858672377 87.60885082 0.0613262 
Ave: 0.0871 1.86509636 87.56602427 0.06129622 
      0.009 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.1067 2.481395349 83.45736434 0.04868346 
  0.1058 2.460465116 83.59689922 0.04876486 
Ave: 0.10625 2.470930233 83.52713178 0.04872416 
pH 5 0.0468 1.066059226 92.8929385 0.05418755 
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  0.0451 1.027334852 93.15110099 0.05433814 
Ave: 0.0460 1.046697039 93.02201974 0.05426284 
pH 7 0.0451 0.965738758 93.56174161 0.05457768 
  0.0444 0.950749465 93.66167024 0.05463597 
Ave: 0.04475 0.958244111 93.61170592 0.05460683 
      0.01 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.1064 2.474418605 83.50387597 0.04383953 
  0.108 2.511627907 83.25581395 0.0437093 
Ave: 0.1072 2.493023256 83.37984496 0.04377442 
pH 5 0.0664 1.512528474 89.91647684 0.04720615 
  0.0694 1.580865604 89.46089598 0.04696697 
Ave: 0.0679 1.546697039 89.68868641 0.04708656 
pH 7 0.0475 1.017130621 93.21912919 0.04894004 
  0.0475 1.017130621 93.21912919 0.04894004 
Ave: 0.0475 1.017130621 93.21912919 0.04894004 
 
 
 
 
 
      0.025 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0185 0.430232558 97.13178295 0.02039767 
  0.022 0.511627907 96.58914729 0.02028372 
Ave: 0.02025 0.470930233 96.86046512 0.0203407 
pH 5 -0.0074 -0.16856492 101.1237661 0.02123599 
  -0.0070 -0.1594533 101.063022 0.02122323 
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Ave: -0.0072 -0.16400911 101.0933941 0.02122961 
pH 7 -0.027 -0.57815846 103.8543897 0.02180942 
  -0.0025 -0.05353319 100.3568879 0.02107495 
Ave: -0.01475 -0.31584582 102.1056388 0.02144218 
      0.05 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0206 0.479069767 96.80620155 0.01016465 
  0.0169 0.393023256 97.37984496 0.01022488 
Ave: 0.01875 0.436046512 97.09302326 0.01019477 
pH 5 0.0112 0.255125285 98.29916477 0.01032141 
  0.0088 0.200455581 98.66362946 0.01035968 
Ave: 0.0100 0.227790433 98.48139711 0.01034055 
pH 7 0.0093 0.199143469 98.67237687 0.0103606 
  0.0079 0.169164882 98.87223412 0.01038158 
Ave: 0.0086 0.184154176 98.7723055 0.01037109 
      0.1 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0074 0.172093023 98.85271318 0.00518977 
  0.0057 0.13255814 99.11627907 0.0052036 
Ave: 0.00655 0.152325581 98.98449612 0.00519669 
pH 5 0.0058 0.132118451 99.11921033 0.00520376 
  0.0060 0.13667426 99.08883827 0.00520216 
Ave: 0.0059 0.134396355 99.1040243 0.00520296 
pH 7 0.0046 0.098501071 99.3433262 0.00521552 
  0.0056 0.119914347 99.20057102 0.00520803 
Ave: 0.0051 0.109207709 99.27194861 0.00521178 
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Amberlite XAD 4 
  0.001 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.462 10.74418605 28.37209302 0.14895349 
  0.4704 10.93953488 27.06976744 0.14211628 
Ave: 0.4662 10.84186047 27.72093023 0.14553488 
pH 5   0 100 0.525 
    0 100 0.525 
Ave:         
pH 7   0 100 0.525 
    0 100 0.525 
Ave:         
      0.004 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.3632 8.446511628 43.68992248 0.05734302 
  0.3769 8.765116279 41.56589147 0.05455523 
Ave: 0.37005 8.605813953 42.62790698 0.05594913 
pH 5   0 100 0.13125 
    0 100 0.13125 
Ave:         
pH 7   0 100 0.13125 
    0 100 0.13125 
Ave:         
      0.0075 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.2544 5.91627907 60.55813953 0.0031793 
  0.2635 6.127906977 59.14728682 0.00310523 
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Ave: 0.25895 6.022093023 59.85271318 0.00314227 
pH 5   0 100 0.00525 
    0 100 0.00525 
Ave:         
pH 7   0 100 0.00525 
    0 100 0.00525 
Ave:         
 
 
 
 
      0.01 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.1136 2.641860465 82.3875969 0.04325349 
  0.1163 2.704651163 81.96899225 0.04303372 
Ave: 0.11495 2.673255814 82.17829457 0.0431436 
pH 5 0.4706 10.71981777 28.53454822 0.01498064 
  0.4916 11.19817768 25.34548216 0.01330638 
Ave: 0.4811 10.95899772 26.94001519 0.01414351 
pH 7 0.6348 13.59314775 9.379014989 0.00492398 
  0.6299 13.4882227 10.07851535 0.00529122 
Ave: 0.63235 13.54068522 9.728765168 0.0051076 
      0.03 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0268 0.623255814 95.84496124 0.01677287 
  0.0203 0.472093023 96.85271318 0.01694922 
Ave: 0.02355 0.547674419 96.34883721 0.01686105 
pH 5 0.3310 7.539863326 49.7342445 0.00870349 
 72 
 
  0.3286 7.485193622 50.09870919 0.00876727 
Ave: 0.3298 7.512528474 49.91647684 0.00873538 
pH 7 0.5752 12.31691649 17.88722341 0.00313026 
  0.5898 12.62955032 15.80299786 0.00276552 
Ave: 0.5825 12.4732334 16.84511064 0.00294789 
      0.05 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0075 0.174418605 98.8372093 0.01037791 
  0.008 0.186046512 98.75968992 0.01036977 
Ave: 0.00775 0.180232558 98.79844961 0.01037384 
pH 5 0.3001 6.835990888 54.42672741 0.00571481 
  0.2993 6.817767654 54.54821564 0.00572756 
Ave: 0.2997 6.826879271 54.48747153 0.00572118 
pH 7 0.4608 9.867237687 34.21841542 0.00359293 
  0.4614 9.880085653 34.13276231 0.00358394 
Ave: 0.4611 9.87366167 34.17558887 0.00358844 
 
 
 
 
 
      0.1 
  Abs Ce(mg/L) % Removal Qe 
pH 4 0.011 0.255813953 98.29457364 0.00516047 
  0.0105 0.244186047 98.37209302 0.00516453 
Ave: 0.01075 0.25 98.33333333 0.0051625 
pH 5 0.2486 5.662870159 62.24753227 0.003268 
  0.2591 5.902050114 60.65299924 0.00318428 
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Ave: 0.2539 5.782460137 61.45026576 0.00322614 
pH 7 0.4101 8.781584582 41.45610278 0.00217645 
  0.4341 9.295503212 38.02997859 0.00199657 
Ave: 0.4221 9.038543897 39.74304069 0.00208651 
      0.5 
  Abs Ce (mg/L) % Removal Qe 
pH 4   0 100 0.00105 
    0 100 0.00105 
Ave:         
pH 5 0.1544 3.517084282 76.55277145 0.0008038 
  0.1567 3.569476082 76.20349279 0.00080014 
Ave: 0.1556 3.543280182 76.37813212 0.00080197 
pH 7   0 100 0.00105 
    0 100 0.00105 
Ave:         
      1 
  Abs Ce (mg/L) % Removal Qe 
pH 4   0 100 0.000525 
    0 100 0.000525 
Ave:         
pH 5 0.1812 4.127562642 72.48291572 0.00038054 
  0.168 3.826879271 74.48747153 0.00039106 
Ave: 0.1746 3.977220957 73.48519362 0.0003858 
pH 7 0.2886 6.219827586 58.53448276 0.00030731 
  0.2956 6.370689655 57.52873563 0.00030203 
Ave: 0.2921 6.295258621 58.0316092 0.00030467 
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  1.5 
  Abs Ce (mg/L) % Removal Qe 
pH 4   0 100 0.00035 
    0 100 0.00035 
Ave:         
pH 5 0.1639 3.733485194 75.11009871 0.00026289 
  0.1619 3.687927107 75.41381929 0.00026395 
Ave: 0.1629 3.71070615 75.261959 0.00026342 
pH 7   0 100 0.00035 
    0 100 0.00035 
Ave:         
      2 
  Abs Ce (mg/L) % Removal Qe 
pH 4   0 100 0.0002625 
    0 100 0.0002625 
Ave:         
pH 5   0 100 0.0002625 
    0 100 0.0002625 
Ave:         
pH 7 0.2838 6.077087794 59.48608137 0.00015615 
  0.2858 6.119914347 59.20057102 0.0001554 
Ave: 0.2848 6.098501071 59.3433262 0.00015578 
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  2.5 
  Abs Ce(mg/L) % Removal Qe 
pH 4   0 100 0.00021 
    0 100 0.00021 
Ave:         
pH 5   0 100 0.00021 
    0 100 0.00021 
Ave:         
pH 7 0.4048 8.668094218 42.21270521 8.8647E-05 
  0.4092 8.762312634 41.58458244 8.7328E-05 
Ave: 0.407 8.715203426 41.89864383 8.7987E-05 
 
 
 
 
 
      3 
  Abs Ce(mg/L) % Removal Qe 
pH 4   0 100 0.000175 
    0 100 0.000175 
Ave:         
pH 5   0 100 0.000175 
    0 100 0.000175 
Ave:         
pH 7 0.335 7.173447537 52.17701642 9.131E-05 
  0.3465 7.419700214 50.53533191 8.8437E-05 
Ave: 0.34075 7.296573876 51.35617416 8.9873E-05 
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Amberlite XAD 7 
  0.01 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.2139 4.974418605 66.8372093 0.03508953 
  0.2218 5.158139535 65.6124031 0.03444651 
Ave: 0.21785 5.06627907 66.2248062 0.03476802 
pH 5 0.5677 12.93166287 13.7889142 0.00723918 
  0.5613 12.78587699 14.76082005 0.00774943 
Ave: 0.5645 12.85876993 14.27486712 0.00749431 
pH 7 0.638 13.66167024 8.92219843 0.00468415 
  0.6416 13.73875803 8.4082798 0.00441435 
Ave: 0.6398 13.70021413 8.665239115 0.00454925 
      0.03 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.1017 2.365116279 84.23255814 0.0147407 
  0.0986 2.293023256 84.71317829 0.01482481 
Ave: 0.10015 2.329069767 84.47286822 0.01478275 
pH 5 0.4778 10.88382688 27.44115414 0.0048022 
  0.4832 11.00683371 26.62110858 0.00465869 
Ave: 0.4805 10.9453303 27.03113136 0.00473045 
pH 7 0.6011 12.87152034 14.18986438 0.00248323 
  0.5862 12.55246253 16.31691649 0.00285546 
Ave: 0.59365 12.71199143 15.25339044 0.00266934 
      0.05 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0573 1.33255814 91.11627907 0.00956721 
  0.0556 1.293023256 91.37984496 0.00959488 
 77 
 
Ave: 0.05645 1.312790698 91.24806202 0.00958105 
pH 5 0.4448 10.13211845 32.45254366 0.00340752 
  0.4542 10.34624146 31.02505695 0.00325763 
Ave: 0.4495 10.23917995 31.7388003 0.00333257 
pH 7 0.5442 11.65310493 22.31263383 0.00234283 
  0.5482 11.73875803 21.74161313 0.00228287 
Ave: 0.5462 11.69593148 22.02712348 0.00231285 
 
 
 
 
      0.1 
  Abs Ce(mg/L) % Removal Qe 
pH 4 0.0492 1.144186047 92.37209302 0.00484953 
  0.0542 1.260465116 91.59689922 0.00480884 
Ave: 0.0517 1.202325581 91.98449612 0.00482919 
pH 5 0.4546 10.35535308 30.96431283 0.00162563 
  0.4586 10.44646925 30.35687168 0.00159374 
Ave: 0.4566 10.40091116 30.66059226 0.00160968 
pH 7 0.509 10.8993576 27.33761599 0.00143522 
  0.5122 10.96788009 26.88079943 0.00141124 
Ave: 0.5106 10.93361884 27.10920771 0.00142323 
      0.5 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0273 0.634883721 95.76744186 0.00100556 
  0.0279 0.648837209 95.6744186 0.00100458 
Ave: 0.0276 0.641860465 95.72093023 0.00100507 
pH 5 0.3428 7.808656036 47.94229309 0.00050339 
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  0.3504 7.981776765 46.7881549 0.00049128 
Ave: 0.3466 7.895216401 47.36522399 0.00049733 
pH 7 0.4953 10.60599572 29.29336188 0.00030758 
  0.5032 10.7751606 28.165596 0.00029574 
Ave: 0.49925 10.69057816 28.72947894 0.00030166 
      0.75 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0884 2.055813953 86.29457364 0.00060406 
  0.0948 2.204651163 85.30232558 0.00059712 
Ave: 0.0916 2.130232558 85.79844961 0.00060059 
pH 5 0.3123 7.113895216 52.57403189 0.00036802 
  0.3098 7.056947608 52.95368261 0.00037068 
Ave: 0.3111 7.085421412 52.76385725 0.00036935 
pH 7 0.4276 9.156316916 38.95788722 0.00027271 
  0.4456 9.541755889 36.38829408 0.00025472 
Ave: 0.4366 9.349036403 37.67309065 0.00026371 
 
 
 
 
 
 
    1 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.106 2.465116279 83.56589147 0.00043872 
  0.1092 2.539534884 83.06976744 0.00043612 
Ave: 0.1076 2.502325581 83.31782946 0.00043742 
pH 5 0.3015 6.867881549 54.21412301 0.00028462 
  0.3021 6.881548975 54.12300683 0.00028415 
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Ave: 0.3018 6.874715262 54.16856492 0.00028438 
pH 7 0.4139 8.862955032 40.91363312 0.0002148 
  0.4136 8.856531049 40.95645967 0.00021502 
Ave: 0.41375 8.859743041 40.9350464 0.00021491 
      2 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.1321 3.072093023 79.51937984 0.00020874 
  0.1317 3.062790698 79.58139535 0.0002089 
Ave: 0.1319 3.06744186 79.5503876 0.00835279 
pH 5 0.2471 5.628701595 62.4753227 0.000164 
  0.2528 5.758542141 61.60971906 0.00016173 
Ave: 0.2500 5.693621868 62.04252088 0.00651446 
pH 7 0.3167 6.781584582 54.78943612 0.00014382 
  0.3267 6.995717345 53.36188437 0.00014007 
Ave: 0.3217 6.888650964 54.07566024 0.00567794 
      3 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.1805 4.197674419 72.01550388 0.00012603 
  0.18 4.186046512 72.09302326 0.00012616 
Ave: 0.18025 4.191860465 72.05426357 0.00012609 
pH 5 0.2581 5.879271071 60.80485953 0.00010641 
  0.2596 5.913439636 60.5770691 0.00010601 
Ave: 0.2589 5.896355353 60.69096431 0.00010621 
pH 7 0.2796 5.987152034 60.0856531 0.00010515 
  0.2874 6.154175589 58.97216274 0.0001032 
Ave: 0.2835 6.070663812 59.52890792 0.00312527 
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Optipore L-493 
  0.01 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.3156 7.339534884 51.06976744 0.02681163 
  0.3148 7.320930233 51.19379845 0.02687674 
Ave: 0.3152 7.330232558 51.13178295 0.02684419 
pH 7 0.4802 10.28265525 31.44896502 0.01651071 
  0.486 10.40685225 30.62098501 0.01607602 
Ave: 0.4831 10.34475375 31.03497502 0.01629336 
      0.05 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0557 1.295348837 91.36434109 0.00959326 
  0.0543 1.262790698 91.58139535 0.00961605 
Ave: 0.055 1.279069767 91.47286822 0.00960465 
pH 7 0.1908 4.085653105 72.76231263 0.00764004 
  0.1903 4.074946467 72.83369022 0.00764754 
Ave: 0.19055 4.080299786 72.79800143 0.00764379 
      0.075 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0233 0.541860465 96.3875969 0.00674713 
  0.0222 0.51627907 96.55813953 0.00675907 
Ave: 0.02275 0.529069767 96.47286822 0.0067531 
pH 7 0.1147 2.456102784 83.62598144 0.00585382 
  0.118 2.526766595 83.15488936 0.00582084 
Ave: 0.11635 2.49143469 83.3904354 0.00583733 
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  0.1 
  Abs Ce(mg/L) % Removal Qe 
pH 4 0.0129 0.30000000 98.00000000 0.005145 
  0.0151 0.351162791 97.65891473 0.00512709 
Ave: 0.014 0.325581395 97.82945736 0.00513605 
pH 7 0.0759 1.625267666 89.16488223 0.00468116 
  0.0696 1.490364026 90.06423983 0.00472837 
Ave: 0.07275 1.557815846 89.61456103 0.00470476 
 
 
 
 
 
    0.2 
  Abs Ce (mg/L) % Removal Qe 
pH 4 0.0042 0.097674419 99.34883721 0.00260791 
  0.0043 0.1 99.33333333 0.0026075 
Ave: 0.00425 0.098837209 99.34108527 0.0026077 
pH 7 0.0185 0.39614561 97.35902926 0.00255567 
  0.0153 0.327623126 97.81584582 0.00256767 
Ave: 0.0169 0.361884368 97.58743754 0.00256167 
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Appendix B: Kinetics Results 
Filtrasorb 200 GAC 
F-200 GAC pH 4 Starting C = 15 mg/L IBP 0.02g GAC 
  0.02 
T (hours) Abs Ce (mg/L) % Removal Qe 
4 0.42335 9.84534884 34.3643411 0.00902064 
8 0.12805 2.97790698 80.1472868 0.021038663 
12 0.025 0.58139535 96.124031 0.025232558 
13.5 0.0194 0.45116279 96.9922481 0.025460465 
15 0.0241 0.56046512 96.2635659 0.001193773 
16 0.02215 0.51511628 96.5658915 0.025348547 
17 0.0138 0.32093023 97.8604651 0.025688372 
18 0.01085 0.25232558 98.3178295 0.02580843 
20 0 0 100   
24 0.0056 0.13023256 99.1317829 0.026022093 
     
     F-200 GAC pH 7 Starting C = 15 mg/L IBP 0.075 g GAC 
  0.075 
T (hours) Abs Ce (mg/L) % Removal Qe 
1.0 0.29565 6.33083512 57.7944325 0.00404561 
2.0 0.0878 1.88008565 87.4660956 0.006122627 
3.0 0.083 1.77730193 88.1513205 0.006170592 
3.5 0.0184 0.39400428 97.3733048 0.006816131 
4.0 0.0415 0.88865096 94.0756602 0.006585296 
8.0 0.0065 0.1391863 99.0720914 0.006935046 
12.0 0.00895 0.19164882 98.7223412 0.006910564 
16.0 0.0212 0.45396146 96.9735903 0.006788151 
20.0 0.01235 0.26445396 98.2369736 0.006876588 
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24.0 0.0146 0.31263383 97.9157744 0.006854104 
 
PWA Powdered Activated Carbon 
 
PWA pH 4 Starting C = 15 mg/L IBP 0.1g 
  0.005 
T (hours) Abs Ce (mg/L) % Removal Qe 
1 0.0068 0.15813953 98.9457364 0.103893023 
2 0.00755 0.1755814 98.8294574 0.10377093 
3 0.00655 0.15232558 98.9844961 0.103933721 
3.5 0.00925 0.21511628 98.5658915 0.103494186 
4 0.00055 0.0127907 99.9147287 0.104910465 
8 0.00335 0.07790698 99.4806202 0.104454651 
12 0.00585 0.13604651 99.0930233 0.104047674 
16 -0.0052 -0.1209302 100.806202 0.105846512 
20 -0.0013 -0.0302326 100.20155 0.105211628 
24 0 0 100 0.105 
     PWA pH 7 Starting C = 15 mg/L IBP 0.025g 
  0.05 
T (hours) Abs Ce (mg/L) % Removal Qe 
1 0.00215 0.04603854 99.6930764 0.010467773 
2 0.0049 0.10492505 99.3004996 0.010426552 
3 0.0049 0.10492505 99.3004996 0.010426552 
3.5 0.00985 0.21092077 98.5938615 0.010352355 
4 -0.0035 -0.0749465 100.499643 0.010552463 
8 0.00175 0.03747323 99.7501784 0.010473769 
12 0.00065 0.01391863 99.9072091 0.010490257 
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16 -0.00275 -0.0588865 100.392577 0.010541221 
20 0.00585 0.12526767 99.1648822 0.010412313 
 
Purolite A530E 
 
Purolite A530E pH 4 Starting C = 15 mg/L IBP 0.1g 
  0.1 
T (hours) Abs Ce (mg/L) % Removal Qe 
3.5 0.02615 0.60813953 95.9457364 0.005037151 
4 0.0198 0.46046512 96.9302326 0.005088837 
8 0.0181 0.42093023 97.1937984 0.005102674 
12 0.02005 0.46627907 96.8914729 0.005086802 
16 0.0185 0.43023256 97.1317829 0.005099419 
18 0.0081 0.18837209 98.744186 0.00518407 
20 0.02635 0.6127907 95.9147287 0.005035523 
22 0.01915 0.44534884 97.0310078 0.005094128 
24 0.0064 0.14883721 99.0077519 0.005197907 
     Purolite A530E pH 7 Starting C = 15 mg/L IBP 0.025g 
  0.025 
T (hours) Abs Ce (mg/L) % Removal Qe 
1 0.41355 8.85546039 40.9635974 0.033602951 
2 0.2664 5.70449679 61.9700214 0.013013704 
3 0.06555 1.40364026 90.6423983 0.019034904 
3.5 0.0386 0.82655246 94.4896502 0.019842827 
4 0.0649 1.38972163 90.7351892 0.01905439 
8 0.0317 0.67880086 95.474661 0.020049679 
12 0.0516 1.10492505 92.633833 0.019453105 
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16 0.02695 0.57708779 96.152748 0.020192077 
20 0.02215 0.47430407 96.8379729 0.020335974 
24 0.0298 0.63811563 95.7458958 0.020106638 
 
Amberlite XAD 4 
XAD-4 pH 4 Starting C = 15 mg/L IBP 0.1g 
  0.1 
T (hours) Abs Ce (mg/L) % Removal Qe 
1 0.2272 5.28372093 64.7751938 0.0034007 
2 0.09785 2.2755814 84.8294574 0.00445355 
3 0.06145 1.42906977 90.4728682 0.00474983 
3.5 0.05435 1.26395349 91.5736434 0.00480762 
4 0.0159 0.36976744 97.5348837 0.00512058 
8 0.0126 0.29302326 98.0465116 0.00514744 
12 0.0169 0.39302326 97.379845 0.00511244 
16 -0.00185 -0.0430233 100.286822 0.00526506 
20 0.02255 0.5244186 96.503876 0.00506645 
24 -0.0004 -0.0093023 100.062016 0.00525326 
     
     XAD-4 pH 7 Starting C = 15 mg/L IBP 0.025g 
  0.025 
T (hours) Abs Ce (mg/L) % Removal Qe 
4 0.5869 12.5674518 16.2169879 
-
0.21284797 
8 0.5769 12.3533191 17.6445396 0.00370535 
12 0.56845 12.1723769 18.8508208 0.00395867 
16 0.57355 12.2815846 18.1227695 0.00380578 
20 0.5632 12.0599572 19.6002855 0.00411606 
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24 0.56475 12.0931478 19.379015 0.00406959 
 
Optipore L-493 
Optipore pH 4 
Starting C = 15 mg/L 
IBP   0.1g 
 
0.1 
T (hours) Abs Ce (mg/L) % Removal Qe 
2 0.014 0.3255814 97.8294574 0.00513605 
4 0.05865 1.36395349 90.9069767 0.00477262 
5 0.05235 1.21744186 91.8837209 0.0048239 
6 0.0513 1.19302326 92.0465116 0.00483244 
7 0.0381 0.88604651 94.0930233 0.03528488 
8 0.02435 0.56627907 96.2248062 0.0050518 
12 0.0202 0.46976744 96.8682171 0.00508558 
16 0.01935 0.45 97 0.0050925 
20 0.0261 0.60697674 95.9534884 0.00503756 
24 0.01605 0.37325581 97.5116279 0.00511936 
     
     
Optipore pH 7 
Starting C = 15 mg/L 
IBP   0.2g 
  0.2 
T (hours) Abs Ce (mg/L) % Removal Qe 
4 0.102 2.18415418 85.4389722 0.02794733 
6 0.0434 0.92933619 93.8044254 0.00246237 
8 0.05395 1.15524625 92.2983583 0.00242283 
10 0.0208 0.44539615 97.0306924 0.00254706 
12 0.03965 0.8490364 94.3397573 0.00247642 
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16 0.0277 0.59314775 96.0456817 0.0025212 
18 0.0073 0.15631692 98.9578872 0.00259764 
20 0.02725 0.58351178 96.1099215 0.00252289 
24 0.0204 0.43683084 97.0877944 0.00254855 
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Appendix C: Adsorbent Fact Sheets 
Filtrasorb 200 Manufacturer Fact Sheet 
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PWA PAC Manufacturer Fact Sheet 
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Amberlite XAD-4 Manufacturer Fact Sheet 
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Amberlite XAD-7 Manufacturer Fact Sheet 
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Purolite A530E Manufacturer Chemical Information 
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Optipore L-493 Manufacturer Chemical Information 
 
